{"gene":"CHUK","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":1995,"finding":"CHUK (IKK-alpha) was identified as a new protein containing a serine-threonine kinase catalytic domain at the N-terminus, a leucine zipper-like amphipathic alpha-helix in the middle, and a helix-loop-helix domain at the C-terminus, suggesting its kinase activity may be targeted to HLH and/or leucine zipper transcription factors.","method":"cDNA cloning and sequence analysis of murine CHUK","journal":"Cellular & molecular biology research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — original cloning and domain architecture identification; structural inference from sequence, not functional reconstitution","pmids":["8777433"],"is_preprint":false},{"year":1997,"finding":"IKK-1 (IKK-alpha) and IKK-2 are components of a large multiprotein IkappaB kinase (IKK) signalsome complex purified from HeLa cells that phosphorylates IkappaB-alpha and IkappaB-beta in response to cytokine stimulation. Mutant IKK-2 affected RelA nuclear translocation and NF-kappaB-dependent reporter activity, establishing both kinases as essential for NF-kappaB activation.","method":"Biochemical purification of the IKK complex from HeLa cells, in vitro kinase assays phosphorylating IkappaB substrates, dominant-negative mutant analysis of NF-kappaB reporter activity","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution with in vitro kinase assay plus functional validation with dominant-negative mutants; foundational study widely replicated","pmids":["9346484"],"is_preprint":false},{"year":1998,"finding":"NF-kappaB-inducing kinase (NIK) preferentially phosphorylates IKK-alpha over IKK-beta specifically on Ser-176 in the activation loop. A Ser-176-to-Ala mutant cannot be phosphorylated or activated by NIK and acts as a dominant negative inhibitor of IL-1- and TNF-induced NF-kappaB activation; a Ser-176-to-Glu mutant is constitutively active.","method":"In vitro kinase assay, site-directed mutagenesis (S176A and S176E), dominant-negative inhibition of NF-kappaB activation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus mutagenesis with gain-of-function and loss-of-function alleles, rigorous mechanistic study","pmids":["9520446"],"is_preprint":false},{"year":1999,"finding":"Both IKK-alpha and IKK-beta are activated by hematopoietic progenitor kinase-1 (HPK1) and MEKK1 stress response kinases. IKK-beta phosphorylated IkappaB constitutively in these assays whereas IKK-alpha was not active in the absence of cell stimulation, indicating differential basal activity.","method":"In vitro kinase assays, overexpression of HPK1 and MEKK1 upstream activators","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase assays with defined upstream activators, single lab","pmids":["10523828"],"is_preprint":false},{"year":1999,"finding":"IKK-1 (IKK-alpha) homodimer has dramatically lower catalytic efficiency toward IkappaB-alpha peptide substrates (k(cat)/K(m) ~0.02 h-1 uM-1) compared to IKK-2 (17.44 h-1 uM-1), while the IKK1/IKK2 heterodimer exhibits the highest catalytic efficiency (47.50 h-1 uM-1). The C-terminus of IkappaB-alpha activates the multisubunit IKK complex through subunits other than IKK-2.","method":"Recombinant protein expression (baculovirus), purification, and kinetic analysis of homodimers vs. heterodimer; peptide substrate kinetics","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — rigorous in vitro reconstitution and kinetic characterization of purified recombinant IKK isoforms with multiple substrates and mutagenesis","pmids":["10823818","10593898"],"is_preprint":false},{"year":2000,"finding":"IKK1 and IKK2 double-knockout mouse embryo fibroblasts completely lack NF-kappaB activity in response to all tested inducers, and double-deficient embryos lose NF-kappaB-lacZ reporter expression in vascular endothelial cells, establishing that IKK1 and IKK2 are together essential for NF-kappaB activation in vivo.","method":"Genetic knockout (IKK1-/- / IKK2-/- double-deficient mice), NF-kappaB reporter (kappaB-lacZ transgene), MEF stimulation assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — double genetic knockout with multiple in vivo and in vitro NF-kappaB readouts","pmids":["10898787"],"is_preprint":false},{"year":2002,"finding":"IKK-alpha homodimers contain non-equivalent active sites: ADP and a peptide inhibitor show differential potency against IkappaBalpha phosphorylation vs. autophosphorylation reactions. The phosphorylation state of the activation loop (S176/S180) affects active site conformation, and autophosphorylation within the homodimer is intramolecular.","method":"Recombinant baculovirus-expressed homodimers, enzyme kinetics, inhibitor analysis, S176E/S180E mutant comparison","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic analysis with mutagenesis; single lab, mechanistically detailed","pmids":["12054687"],"is_preprint":false},{"year":2003,"finding":"Vav-1 constitutively associates with IKK-alpha (but not IKK-beta) in Jurkat and primary CD4+ T cells via their helix-loop-helix domains. CD28 engagement increases Vav-1-associated IKK-alpha kinase activity, and both IKK-alpha and Vav-1 augment CD28-induced NF-kappaB activation. Vav-1 and IKK-alpha (but not IKK-beta) colocalize at the membrane upon CD28 stimulation.","method":"Co-immunoprecipitation, in vitro kinase assay, NF-kappaB reporter assay, confocal microscopy","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, kinase activity assay, and imaging in the same study; single lab","pmids":["12626540"],"is_preprint":false},{"year":2003,"finding":"EBV LMP1 induces p100/NF-kappaB2 processing to p52 in human lymphoblasts via a NIK/IKKalpha-dependent and IKKbeta/IKKgamma-independent mechanism. IKKalpha knockout MEFs show loss of LMP1-induced MIG and CXCR4 upregulation, while IKKalpha absence hyperinduces MIP-2, TNF-alpha, and I-TAC, indicating IKKalpha's dual role in promoting noncanonical and downmodulating canonical NF-kappaB signaling.","method":"Genetic knockout MEFs (IKKalpha KO), dominant-negative IKK constructs, RNA expression analysis, NF-kappaB pathway dissection","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout cells with multiple NF-kappaB pathway readouts, pathway placement by epistasis","pmids":["14691250"],"is_preprint":false},{"year":2004,"finding":"IKK-alpha has a dual NF-kappaB-dependent role (cusp formation) and an NF-kappaB-independent role (direction of epithelial invagination vs. evagination in incisor and whisker development) in tooth and ectodermal appendage development in mice.","method":"Ikkα mutant mouse analysis, genetic comparison with cIκBαΔN transgenic mice (NF-kappaB blocking), examination of Notch/Wnt/Shh pathway markers","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis using two distinct mouse models with clear phenotypic readouts separating NF-kappaB-dependent from independent functions","pmids":["14960276"],"is_preprint":false},{"year":2004,"finding":"IKKalpha, IKKbeta, IKKepsilon, and TBK1 can all phosphorylate p65/RelA at Ser-536. IKKepsilon and TBK1 phosphorylate Ser-536 in vivo and in vitro. Importantly, IKKalpha/beta RNAi knockdown or IKKbeta inhibitor alone could not suppress Ser-536 phosphorylation, suggesting IKK-independent pathways also contribute.","method":"RNA interference, pharmacological inhibitors, chromatographic fractionation, in vitro kinase assay, reconstitution in p65-deficient fibroblasts","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal methods but complex multi-kinase picture; single lab","pmids":["15489227"],"is_preprint":false},{"year":2005,"finding":"IKK1 (IKKalpha) knockout macrophages show enhanced NF-kappaB activity due to prolonged IkappaBalpha degradation after pathogen stimulation, caused by uncontrolled IKK2 kinase activity. This reveals IKK1 functions as a checkpoint to control IKK2-mediated IkappaBalpha phosphorylation in innate immunity.","method":"IKK1-/- embryonic liver-derived macrophages, NF-kappaB activity assay, IKK2 kinase assay, cytokine secretion measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout macrophages with multiple functional readouts and mechanistic pathway placement","pmids":["16116086"],"is_preprint":false},{"year":2005,"finding":"IKKalpha is required for RANK ligand-induced osteoclast formation in vitro but is not required in vivo for osteoclastogenesis, while IKKbeta is required both in vitro and in vivo. This establishes distinct and non-redundant roles for IKKalpha and IKKbeta downstream of RANK signaling.","method":"Conditional knockout mice (hematopoietic-specific), in vitro osteoclastogenesis assays, inflammation-induced bone loss model","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in vivo and in vitro with two different conditional knockouts","pmids":["15897281"],"is_preprint":false},{"year":2006,"finding":"IKKalpha regulates estrogen-induced cell cycle progression by controlling transcription of the E2F1 gene and E2F1-responsive genes. Estrogen treatment increases association of endogenous IKKalpha with E2F1 on E2F1-bound promoters, and IKKalpha potentiates p300/CBP-associated factor-mediated acetylation of E2F1.","method":"siRNA knockdown of IKKalpha, chromatin immunoprecipitation, Co-immunoprecipitation, gene expression analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and co-IP with functional readout; single lab","pmids":["16407216"],"is_preprint":false},{"year":2006,"finding":"p63 (TAp63 isoform) directly and indirectly transactivates IKKalpha and Ets-1, respectively, in a genetic pathway upstream of IKKalpha during epidermal development. DeltaNp63 upregulates IKKalpha indirectly through GATA-3. Genetic complementation in mice confirmed this p63→IKKalpha epistatic relationship.","method":"Molecular analyses (transcriptional assays), genetic complementation in mice, in vivo epistasis","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis established by in vivo complementation combined with molecular mechanistic analysis","pmids":["17093266"],"is_preprint":false},{"year":2007,"finding":"ATM kinase phosphorylates IKK-alpha at Ser-473 in response to cisplatin treatment, causing nuclear accumulation of IKK-alpha, which then stabilizes p73 to promote apoptosis. IKKalpha-deficient MEFs show cisplatin-resistant phenotype.","method":"In vitro kinase assay (ATM phosphorylates IKK-alpha), site identification, immunofluorescence colocalization, IKKalpha-deficient MEF functional assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay identifying phosphorylation site plus loss-of-function phenotype; single lab","pmids":["17700524"],"is_preprint":false},{"year":2007,"finding":"IKK-alpha mediates chromatin modification on pro-inflammatory gene promoters in response to cigarette smoke: it phosphorylates histone H3 Ser-10 and promotes acetylation of H3 Lys-9 and RelA/p65 Lys-310, leading to sustained transcription of IL-6 and MIP-2. Dominant-negative IKK-alpha reduced CS-induced chromatin modification.","method":"Chromatin immunoprecipitation, gain-of-function overexpression, dominant-negative mutant transfection, in vivo mouse lung CS exposure","journal":"American journal of respiratory cell and molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with gain- and loss-of-function experiments; single lab, in vivo and in vitro","pmids":["18239189"],"is_preprint":false},{"year":2007,"finding":"NIK differentially regulates IKK-alpha-mediated activation of IRF3/7 vs. NF-kappaB: IKKalpha-S176E constitutively activates IRF3/7, while IKKalpha-S180E loses the ability to activate IRF3/7, demonstrating that the two NIK-phosphorylation sites on IKKalpha differentially govern its downstream effector functions.","method":"Site-directed mutagenesis (S176E, S180E), overexpression, IFN-alpha promoter reporter assay, NF-kappaB reporter assay","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis with functional readouts for two distinct downstream pathways; single lab","pmids":["18068231"],"is_preprint":false},{"year":2007,"finding":"IKK1/IKKalpha and IKKbeta are both required for S. pneumoniae-induced MUC5AC mucin upregulation via an ERK1-dependent but IkappaBalpha-p65- and p100-p52-independent mechanism, revealing novel NF-kappaB-independent roles for IKKs in innate mucosal defense.","method":"Dominant-negative IKK constructs, siRNA knockdown, pathway inhibitors, ERK dependency assays, in vivo mouse model","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple loss-of-function approaches; single lab with in vivo confirmation","pmids":["17237423"],"is_preprint":false},{"year":2007,"finding":"Keratinocyte-specific IKK1 ablation causes impaired epidermal-barrier function and increased transepidermal water loss due to defects in stratum corneum lipid composition and epidermal tight junctions, mediated by deregulation of retinoic acid receptor target genes. IKK1 is recruited to promoters of retinoic acid-regulated genes, indicating a role in RA-regulated transcription.","method":"Conditional knockout mice (keratinocyte-specific IKK1 ablation), barrier function assays, chromatin immunoprecipitation, retinoic acid-induced gene expression analysis","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional genetic knockout with ChIP and multiple functional readouts; rigorous mechanistic study","pmids":["17351639"],"is_preprint":false},{"year":2008,"finding":"BAFF activates Akt and Erk in primary mouse B cells through BAFF-R in an IKK1-dependent manner, establishing IKK1 as a coordinator of multiple BAFF-R-mediated survival signaling pathways beyond NF-kappaB.","method":"IKK1 conditional knockout B cells, BAFF stimulation, Akt and Erk phosphorylation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic conditional knockout with defined signaling readouts in primary cells","pmids":["18713867"],"is_preprint":false},{"year":2008,"finding":"Combined conditional ablation of IKK1 and IKK2 (but not each alone) in hepatocytes sensitizes the liver to LPS/TNF-induced failure, revealing redundancy in canonical NF-kappaB signaling. Additionally, combined ablation of IKK1+IKK2 or IKK1+NEMO causes spontaneous fatal cholangitis involving IKK1-specific functions affecting the bile-blood barrier, revealing a novel IKK1-specific function in bile duct integrity.","method":"Conditional double-knockout mice (liver-specific), in vivo LPS challenge, histopathology","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple conditional genetic knockout combinations dissecting redundant and specific functions in vivo","pmids":["18606991"],"is_preprint":false},{"year":2008,"finding":"IKKalpha/beta-phosphorylated IkappaBalpha plays a role in axon outgrowth and axon initial segment (AIS) development in hippocampal neurons. Inhibition of IkappaBalpha phosphorylation by IKKs impedes axon outgrowth and impairs localization of ankyrin G and voltage-gated sodium channels at the AIS.","method":"Pharmacological inhibition of IKK kinase activity in cultured hippocampal neurons, immunofluorescence for AIS markers","journal":"Molecular and cellular neurosciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pharmacological inhibitor with imaging; does not cleanly separate IKK-alpha from IKK-beta contributions; single lab","pmids":["18321726"],"is_preprint":false},{"year":2010,"finding":"The L. monocytogenes secreted protein InlC directly interacts with IKKalpha and impairs IkappaB phosphorylation and degradation normally induced by TNF-alpha, thus dampening host NF-kappaB-dependent innate immune responses during infection.","method":"Protein-protein interaction assay (direct binding), infection assays with WT vs. inlC-deletion mutant, cytokine measurement, mouse peritonitis model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding established, functional consequence demonstrated in vitro and in vivo with genetic deletion","pmids":["20855622"],"is_preprint":false},{"year":2010,"finding":"IKKalpha is necessary for TGFbeta-SMAD-mediated epithelial-mesenchymal transition (EMT) in Panc1 cells, independently of NF-kappaB. IKKalpha interacts with SMAD3 and controls SMAD complex formation on DNA to regulate transcription of SNAIL and SLUG genes.","method":"IKKalpha siRNA knockdown, Co-immunoprecipitation of IKKalpha with SMAD3, chromatin immunoprecipitation, gene expression analysis in Panc1 and MDA-MB231 cells","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with functional readout, replicated in two cell lines; single lab","pmids":["21081648"],"is_preprint":false},{"year":2010,"finding":"Loss of CHUK (IKKalpha) causes a lethal autosomal recessive fetal syndrome with severe craniofacial and limb malformations in humans, confirming IKKalpha is essential for skin epidermis and ectodermal derivative development.","method":"Human genetics (identification of point mutation), candidate-gene analysis, gene-expression arrays in affected fetuses","journal":"The New England journal of medicine","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — human loss-of-function genetics establishing essential developmental role; no in vitro mechanistic reconstitution","pmids":["20961246"],"is_preprint":false},{"year":2010,"finding":"In zebrafish, the maternal effect gene poky/chuk/ikk1 is required for EVL differentiation via its kinase activity but not via its HLH domain, in contrast to the mouse where the HLH domain is important, demonstrating conservation of the requirement for Ikk1 in epidermal differentiation with divergent molecular mechanisms.","method":"Zebrafish genetic (poky mutant), kinase-dead and HLH-domain mutant rescue experiments, cell cycle and differentiation marker analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic model with domain-specific rescue experiments; single lab","pmids":["20692251"],"is_preprint":false},{"year":2011,"finding":"Nuclear IKKalpha is present in resting CD4+ T cells and upon Th17 differentiation selectively associates with the Il17a gene locus to promote histone H3 phosphorylation and transcriptional activation of IL-17a in an NF-kappaB-independent manner.","method":"Chromatin immunoprecipitation (IKKalpha at Il17a locus), non-activatable IKKalpha knock-in T cells, Th17 differentiation assay, histone modification analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP demonstrating direct chromatin occupancy, genetic non-activatable knockin with functional differentiation phenotype","pmids":["21402739"],"is_preprint":false},{"year":2011,"finding":"IKK1 inactivation in keratinocytes results in increased p63 expression and repression of Notch signaling. Forced expression of the Notch1 intracellular domain (NICD) partially rescues the differentiation defect of IKK1-/- keratinocytes, placing IKK1 upstream of Notch in epidermal differentiation.","method":"Ikk1 genetic inactivation in keratinocytes, NICD overexpression rescue, p63 RNAi knockdown, gene expression analysis","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic rescue experiment establishing pathway order; single lab","pmids":["21435444"],"is_preprint":false},{"year":2013,"finding":"IKKalpha acts independent of its kinase activity to drive chondrocyte hypertrophic differentiation. IKKalpha positively modulates ECM remodeling via multiple downstream targets including MMP-10 and TIMP-3, to maintain maximal MMP-13 collagenase activity. Differentiation of IKKalpha-deficient chondrocytes was rescued by a kinase-dead IKKalpha mutant.","method":"Cre-lox conditional IKKalpha knockout chondrocytes, kinase-dead mutant rescue, mRNA profiling, immunoblotting, MMP activity assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with kinase-dead rescue establishing kinase-independent function, multiple orthogonal methods","pmids":["24023802"],"is_preprint":false},{"year":2013,"finding":"HCV via its 3' UTR interacts with DDX3X to activate IKK-alpha, which translocates to the nucleus and induces a CBP/p300-mediated transcriptional program involving SREBPs to upregulate lipogenic genes and enhance lipid droplet formation for viral assembly, independently of NF-kappaB.","method":"siRNA knockdown, chemical inhibitors of IKK-alpha, RNA-protein interaction, nuclear translocation assay, lipid droplet imaging, SREBP transcriptional assay","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods establishing a novel nuclear NF-kappaB-independent function with loss-of-function and mechanistic pathway dissection","pmids":["23708292"],"is_preprint":false},{"year":2014,"finding":"Survivin-2B stabilizes IKK-alpha in the nucleus of NB4 cells; decreased survivin-2B leads to reduced nuclear IKK-alpha, which reduces P73 levels and consequently reduces UVRAG expression, switching protective autophagy to apoptosis.","method":"Co-immunoprecipitation (survivin-2B/IKK-alpha interaction in nucleus), nuclear fractionation, gene knockdown, in vivo tumor model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and functional pathway analysis; single lab with in vivo confirmation","pmids":["24556686"],"is_preprint":false},{"year":2015,"finding":"Upon HCV infection, DDX3X and IKK-alpha redistribute to stress granules (SGs) upon interaction with the HCV 3' UTR. Subsequently, IKK-alpha translocates to the nucleus while DDX3X and SG proteins redistribute to lipid droplet surfaces. Multiple HCV nonstructural proteins colocalize with DDX3X near SGs and LDs.","method":"Systematic imaging (live cell and fixed), biochemical fractionation, co-immunoprecipitation, siRNA knockdown of DDX3X and SG components","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — imaging and biochemical methods; single lab confirming and extending prior findings","pmids":["25740981"],"is_preprint":false},{"year":2016,"finding":"X-ray crystal structure and cryo-EM structure of human IKK1 revealed dimeric and hexameric (trimer of dimers) forms. A surface critical for hexamer formation is essential for IKK1-dependent cellular p100-to-p52 processing (non-canonical NF-kappaB signaling), and this surface is divergent from IKK2, providing structural basis for distinct signaling by the two kinases.","method":"Single-particle cryo-EM, X-ray crystallography, mutagenesis of hexamer-forming surface, p100 processing assay in cells","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Strong — structural determination by two orthogonal methods (cryo-EM and X-ray) combined with functional mutagenesis validating the identified surface","pmids":["27851956"],"is_preprint":false},{"year":2016,"finding":"RelB competes with the NIK:IKK1 complex for binding to a shared region of p100 within a transitional complex containing RelB, NIK, IKK1, and p100. This competition modulates the balance between p100 processing to p52 (generating active RelB:p52) and protection of p100 as part of the kappaBsome, controlling non-canonical NF-kappaB signaling output.","method":"Co-immunoprecipitation mapping interaction domains, p100 processing assays, analysis of kappaBsome formation","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP with functional p100 processing readout; single lab, mechanistically detailed","pmids":["27678221"],"is_preprint":false},{"year":2018,"finding":"DCNL5 is directly phosphorylated by IKK-alpha (but not IKK-beta) on Ser-41 upon Toll-like receptor activation, identifying DCNL5 as a specific IKK-alpha substrate in innate immune signaling and the first DCNL member known to be regulated by kinase-mediated phosphorylation.","method":"In vitro kinase assay (IKKalpha vs. IKKbeta specificity), phosphorylation site mapping (S41), TLR stimulation assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with site identification and specificity determination; single lab","pmids":["29958295"],"is_preprint":false},{"year":2018,"finding":"IKK1/IKK2 double-deficient human cells (generated by CRISPR/Cas9n) show increased TNF-induced apoptosis mediated via RIPK1 in a predominantly apoptotic manner, independently of NF-kappaB RelA. Single IKK1 or IKK2 deficiency does not increase cell death, demonstrating a redundant, NF-kappaB-independent pro-survival function of the IKK complex.","method":"CRISPR/Cas9n knockout of IKK1, IKK2, IKK1/2 double, and RELA; caspase-3 activation, Annexin V binding, RIPK1 inhibition","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean CRISPR knockouts with multiple readouts; single lab","pmids":["29630899"],"is_preprint":false},{"year":2019,"finding":"Inducible IKKalpha knockout in adult chondrocytes reduces cartilage degradation, collagenase activity, and hypertrophy-like features in the destabilization of medial meniscus (DMM) mouse model of post-traumatic OA, confirming an in vivo kinase-independent role for IKKalpha in OA-associated cartilage degradation.","method":"Tamoxifen-inducible conditional knockout (AcanCreERT2/+; IKKαf/f mice), DMM surgical OA model, histopathology, collagenase activity assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible conditional genetic knockout in adult tissue-specific cells with quantitative in vivo readouts","pmids":["31222033"],"is_preprint":false},{"year":2019,"finding":"IKKalpha/CHUK acts as a tumor suppressor in lung epithelial cells: its loss in AT-II cells increases lung adenoma number and size after chemical carcinogen treatment, and IKKalpha knockdown in human NSCLC lines enhances xenograft tumor growth associated with upregulation of activated HIF-1alpha under hypoxia.","method":"Tamoxifen-inducible conditional IKKalpha knockout in AT-II cells, urethane carcinogenesis model, human NSCLC xenografts, transcriptome profiling, HIF-1alpha protein analysis","journal":"Life science alliance","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent in vivo cancer models with mechanistic validation via transcriptome profiling; single lab","pmids":["31792060"],"is_preprint":false},{"year":2021,"finding":"IKK-alpha in lymphatic endothelial cells (LECs) is absolutely essential for lymph node formation, while IKK-alpha in hematopoietic cells (but not LECs) is required for mature B cell homeostasis. These two functions are mediated by distinct IKK-alpha-expressing cell populations.","method":"Tissue-specific conditional knockout mice (Tie2-cre, Cdh5-cre, LEC-specific Lyve1-cre, hematopoietic-specific), analysis of lymph node formation and B cell numbers","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple cell-type-specific conditional knockouts dissecting distinct physiological roles in vivo","pmids":["34810256"],"is_preprint":false},{"year":2021,"finding":"NIK, by binding to IKK1, also associates with IKK2 and NEMO, allowing NIK to direct phosphorylation of IKK2 independently of IKK1's enzymatic function. IKK2 activation is maintained even when NIK's interaction with IKK1/NF-kappaB2 is compromised by specific NIK mutation, demonstrating that NIK-IKK1 and NIK-IKK2 activation pathways are not strictly coupled.","method":"NIK interaction-domain mutant knock-in mice, IKK1/IKK2 co-immunoprecipitation with NIK, NF-kappaB pathway activation assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — knock-in mutation combined with co-IP and in vivo pathway analysis; single recent paper with rigorous genetic approach","pmids":["41060807"],"is_preprint":false},{"year":2022,"finding":"O-GlcNAc-modified NLRX1 interacts with IKK-alpha in M1 macrophages; elevated O-GlcNAcylation enhances the NLRX1/IKK-alpha interaction, and this enhanced interaction reduces IL-1beta expression, suggesting IKK-alpha is regulated by NLRX1 in a post-translational modification-dependent manner.","method":"Co-immunoprecipitation, confocal colocalization, ubiquitination assay, OGT inhibitor treatment, IL-1beta expression measurement","journal":"In vitro cellular & developmental biology. Animal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single co-IP study; indirect evidence for IKK-alpha functional regulation; single lab","pmids":["35513753"],"is_preprint":false}],"current_model":"CHUK/IKK-alpha is a serine-threonine kinase and core component of the IKK signalsome that, when activated by upstream kinases such as NIK (via phosphorylation of Ser-176), phosphorylates IkappaB proteins to trigger NF-kappaB activation (primarily through the non-canonical pathway via p100-to-p52 processing), while also exerting kinase-independent roles in epidermal differentiation, chondrocyte hypertrophy, and ECM remodeling; nuclear IKK-alpha additionally functions as a chromatin-modifying kinase (phosphorylating histone H3 and RelA at specific residues) to regulate Th17, pro-inflammatory, and HCV-lipogenic transcriptional programs independently of canonical NF-kappaB; its structural basis involves a dimeric/hexameric architecture whose hexamer-forming surface specifically mediates non-canonical signaling; and it is placed downstream of p63 and upstream of Notch/Wnt/Shh in skin development, with distinct cell-type-specific (lymphatic endothelial, hematopoietic, chondrocyte, lung epithelial) functions established by conditional genetics."},"narrative":{"mechanistic_narrative":"CHUK/IKK-alpha is a serine-threonine kinase, identified by its N-terminal kinase domain plus central leucine-zipper and C-terminal helix-loop-helix domains [PMID:8777433], that operates as a core catalytic subunit of the multiprotein IkappaB kinase (IKK) signalsome which phosphorylates IkappaB proteins to drive NF-kappaB activation [PMID:9346484]. IKK-alpha is activated through phosphorylation of its activation-loop residue Ser-176 by NIK and by stress kinases such as HPK1/MEKK1, with an S176E substitution rendering it constitutively active [PMID:9520446, PMID:10523828]; in vitro the IKK-alpha homodimer is a comparatively weak kinase while the IKK-alpha/IKK-beta heterodimer is most efficient toward IkappaB-alpha [PMID:10823818, PMID:10593898], and the two kinases are together essential for NF-kappaB activation in vivo [PMID:10898787]. A defining feature of IKK-alpha is its selective control of the non-canonical pathway, mediating NIK-dependent p100-to-p52 processing [PMID:14691250] through a hexamer-forming surface, divergent from IKK-beta, that structural analysis shows is required for p100 processing [PMID:27851956], with RelB competing for p100 to set signaling output [PMID:27678221]; reciprocally, IKK-alpha restrains canonical IKK-beta-driven IkappaB-alpha degradation as an innate-immunity checkpoint [PMID:16116086]. Beyond cytoplasmic kinase activity, nuclear IKK-alpha acts as a chromatin-modifying kinase, phosphorylating histone H3 and modulating RelA acetylation to sustain pro-inflammatory transcription [PMID:18239189, PMID:21402739], and is exploited by HCV—via DDX3X and the viral 3' UTR—to drive an SREBP/CBP-p300 lipogenic program independently of NF-kappaB [PMID:23708292]. IKK-alpha additionally performs kinase-independent developmental and structural roles, including epidermal barrier formation via retinoic-acid-regulated transcription [PMID:17351639], placement downstream of p63 and upstream of Notch in keratinocyte differentiation [PMID:17093266, PMID:21435444], and chondrocyte hypertrophy and ECM remodeling rescued by kinase-dead protein [PMID:24023802, PMID:31222033]. Distinct cell-type-specific in vivo functions—lymphatic endothelial cells for lymph node formation, hematopoietic cells for B cell homeostasis—have been established by conditional genetics [PMID:34810256], and IKK-alpha behaves as a lung epithelial tumor suppressor whose loss promotes adenoma growth and HIF-1alpha accumulation [PMID:31792060]. In humans, biallelic loss of CHUK causes a lethal autosomal recessive fetal syndrome with severe craniofacial and limb malformations [PMID:20961246].","teleology":[{"year":1995,"claim":"Established the protein's existence and domain architecture, predicting that a kinase carrying leucine-zipper and HLH motifs might target transcription factors.","evidence":"cDNA cloning and sequence analysis of murine CHUK","pmids":["8777433"],"confidence":"Medium","gaps":["No functional kinase substrate identified","No demonstration of complex membership or signaling role"]},{"year":1997,"claim":"Placed IKK-alpha within the cytokine-responsive IKK signalsome and showed it phosphorylates IkappaB substrates, answering what the kinase does in NF-kappaB signaling.","evidence":"Biochemical purification of the IKK complex from HeLa cells, in vitro kinase assays, dominant-negative analysis","pmids":["9346484"],"confidence":"High","gaps":["Relative contributions of IKK-alpha vs IKK-beta not resolved","Upstream activators of the complex not defined"]},{"year":1998,"claim":"Defined the upstream activation mechanism by showing NIK phosphorylates IKK-alpha at Ser-176 in the activation loop, with phospho-mimetic and dead alleles toggling activity.","evidence":"In vitro kinase assay and S176A/S176E site-directed mutagenesis","pmids":["9520446"],"confidence":"High","gaps":["Did not establish in vivo pathway selectivity of NIK-IKK-alpha","Role of second activation-loop site (S180) not addressed"]},{"year":1999,"claim":"Quantified the catalytic hierarchy of IKK isoforms, showing IKK-alpha homodimer is weakly active while the heterodimer is most efficient and that additional stress kinases activate IKK-alpha.","evidence":"Recombinant homodimer/heterodimer kinetics and overexpression of HPK1/MEKK1","pmids":["10823818","10593898","10523828"],"confidence":"High","gaps":["In vivo relevance of the heterodimer kinetic advantage untested","Differential basal activity mechanism unexplained"]},{"year":2000,"claim":"Demonstrated genetically that IKK-alpha and IKK-beta are together indispensable for NF-kappaB activation in vivo, resolving whether the kinases are essential.","evidence":"IKK1/IKK2 double-knockout mice and MEFs with kappaB-lacZ reporter","pmids":["10898787"],"confidence":"High","gaps":["Did not separate unique IKK-alpha functions from IKK-beta","Non-canonical pathway not specifically dissected"]},{"year":2002,"claim":"Refined the catalytic mechanism by showing IKK-alpha homodimers contain non-equivalent active sites and that activation-loop phosphorylation alters active-site conformation via intramolecular autophosphorylation.","evidence":"Recombinant homodimer enzyme kinetics, inhibitor analysis, S176E/S180E mutants","pmids":["12054687"],"confidence":"Medium","gaps":["Single-lab in vitro analysis","Physiological consequence of active-site asymmetry untested"]},{"year":2003,"claim":"Identified IKK-alpha-specific signaling roles, both as a Vav-1-associated kinase in T-cell costimulation and as the selective mediator of LMP1-induced non-canonical p100 processing, distinguishing it from IKK-beta.","evidence":"Co-IP/kinase assays in T cells and IKK-alpha-knockout MEFs with NF-kappaB pathway readouts","pmids":["12626540","14691250"],"confidence":"High","gaps":["Mechanism of IKK-alpha selectivity for p100 not structurally defined","Direct p100 phosphorylation by IKK-alpha not shown here"]},{"year":2004,"claim":"Revealed kinase-independent and NF-kappaB-independent developmental roles and broadened the substrate landscape to RelA Ser-536, separating IKK-alpha functions from canonical signaling.","evidence":"Ikka mutant vs cIkBaDN mouse epistasis in tooth/ectoderm; multi-kinase RelA S536 phosphorylation analysis","pmids":["14960276","15489227"],"confidence":"Medium","gaps":["Direct molecular targets of NF-kappaB-independent developmental role unknown","RelA S536 phosphorylation has redundant kinase inputs"]},{"year":2005,"claim":"Established IKK-alpha as a negative checkpoint on canonical IKK-beta activity and assigned distinct cell-type-specific roles in osteoclast and bone biology.","evidence":"IKK1-knockout macrophages and hematopoietic/conditional knockouts with functional readouts","pmids":["16116086","15897281"],"confidence":"High","gaps":["Molecular basis of IKK-alpha checkpoint on IKK-beta unclear","In vitro vs in vivo discordance in osteoclastogenesis unexplained"]},{"year":2006,"claim":"Documented nuclear chromatin-associated functions of IKK-alpha at gene promoters, controlling E2F1 transcription and acetylation, and identified p63 as upstream in epidermal development.","evidence":"siRNA, ChIP and co-IP for E2F1; transcriptional assays and mouse genetic complementation for p63","pmids":["16407216","17093266"],"confidence":"Medium","gaps":["Direct kinase substrate at chromatin not always identified","Generality of promoter recruitment unknown"]},{"year":2007,"claim":"Defined IKK-alpha as a stress- and damage-responsive nuclear chromatin-modifying kinase (ATM-driven nuclear accumulation; H3 Ser-10 phosphorylation) and showed activation-loop sites differentially gate IRF3/7 vs NF-kappaB outputs.","evidence":"In vitro kinase assays, ChIP, dominant-negative and S176E/S180E mutant reporter assays, knockout MEFs","pmids":["17700524","18239189","18068231"],"confidence":"Medium","gaps":["Single-lab studies for each effector branch","How site-specific phosphorylation routes effector choice mechanistically unclear"]},{"year":2007,"claim":"Demonstrated epidermal-barrier and innate-defense roles, including RA-regulated transcription in keratinocytes and NF-kappaB-independent ERK-dependent mucin induction.","evidence":"Keratinocyte-specific IKK1 knockout with ChIP; dominant-negative/siRNA mucin assays in vivo","pmids":["17351639","17237423"],"confidence":"High","gaps":["Direct IKK-alpha substrates in RA-regulated transcription not defined","Kinase dependence of mucin role not fully resolved"]},{"year":2008,"claim":"Extended IKK-alpha function to BAFF-R survival signaling, hepatic/bile-duct integrity, and axonal development, revealing redundant and IKK1-specific physiological roles.","evidence":"Conditional B-cell and liver knockouts; pharmacological IKK inhibition in neurons","pmids":["18713867","18606991","18321726"],"confidence":"High","gaps":["Neuronal study cannot separate IKK-alpha from IKK-beta","Mechanism linking IKK1 to Akt/Erk activation unknown"]},{"year":2010,"claim":"Identified IKK-alpha as a target of bacterial immune evasion and as a SMAD3-associated driver of NF-kappaB-independent EMT, and established its essential developmental role in humans.","evidence":"InlC direct binding/infection models; co-IP/ChIP for SMAD3-EMT; human loss-of-function genetics; zebrafish domain-specific rescue","pmids":["20855622","21081648","20961246","20692251"],"confidence":"High","gaps":["Direct phosphorylation events in EMT not defined","Human syndrome lacks in vitro mechanistic reconstitution","Kinase vs HLH requirement differs across species"]},{"year":2011,"claim":"Solidified IKK-alpha as a nuclear lineage-specifying chromatin kinase by showing direct occupancy and H3 phosphorylation at the Il17a locus during Th17 differentiation, and placed IKK1 upstream of Notch in keratinocytes.","evidence":"ChIP and non-activatable IKK-alpha knock-in T cells; NICD rescue of IKK1-null keratinocytes","pmids":["21402739","21435444"],"confidence":"High","gaps":["How nuclear IKK-alpha is targeted to specific loci unknown","Direct chromatin substrate repertoire incomplete"]},{"year":2013,"claim":"Defined a kinase-independent structural/regulatory role in chondrocyte hypertrophy and ECM remodeling, and a nuclear lipogenic transcriptional program co-opted by HCV.","evidence":"Conditional knockout chondrocytes with kinase-dead rescue; siRNA/inhibitor HCV lipogenesis with SREBP/CBP-p300 readouts","pmids":["24023802","23708292"],"confidence":"High","gaps":["Molecular partners mediating kinase-independent chondrocyte role not identified","Direct IKK-alpha nuclear substrate in HCV program undefined"]},{"year":2014,"claim":"Linked nuclear IKK-alpha stability to a survivin-2B-dependent p73/UVRAG axis controlling the autophagy-apoptosis switch.","evidence":"Nuclear co-IP, fractionation, knockdown, in vivo tumor model","pmids":["24556686"],"confidence":"Medium","gaps":["Single-lab pathway","Whether IKK-alpha kinase activity is required not established"]},{"year":2015,"claim":"Mapped the spatial trafficking of IKK-alpha during HCV infection through stress granules to the nucleus, supporting the lipogenesis model.","evidence":"Live and fixed imaging, fractionation, co-IP, siRNA of DDX3X/SG components","pmids":["25740981"],"confidence":"Medium","gaps":["Trigger for nuclear translocation not defined","Single-lab observation"]},{"year":2016,"claim":"Provided the structural basis for IKK-alpha's selective non-canonical function, showing a hexamer-forming surface required for p100 processing and a RelB competition mechanism setting signaling output.","evidence":"Cryo-EM and X-ray structures with hexamer-surface mutagenesis; co-IP mapping of RelB/NIK/IKK1/p100 complex","pmids":["27851956","27678221"],"confidence":"High","gaps":["How hexamer assembly is regulated in cells unknown","Structure of the full active signalsome not resolved"]},{"year":2018,"claim":"Identified a specific IKK-alpha substrate (DCNL5 Ser-41) in innate immunity and demonstrated a redundant NF-kappaB-independent pro-survival role of the IKK complex against TNF/RIPK1-driven apoptosis.","evidence":"In vitro kinase specificity assays; CRISPR/Cas9n single and double IKK knockouts in human cells","pmids":["29958295","29630899"],"confidence":"Medium","gaps":["Functional consequence of DCNL5 phosphorylation incompletely defined","Mechanism of IKK restraint on RIPK1 unclear"]},{"year":2019,"claim":"Confirmed in vivo kinase-independent IKK-alpha function in osteoarthritic cartilage degradation and established IKK-alpha as a lung epithelial tumor suppressor restraining HIF-1alpha.","evidence":"Inducible chondrocyte knockout DMM model; inducible AT-II knockout carcinogenesis and NSCLC xenografts with transcriptome profiling","pmids":["31222033","31792060"],"confidence":"High","gaps":["Mechanism by which kinase-dead IKK-alpha drives ECM remodeling unknown","Direct link between IKK-alpha and HIF-1alpha regulation undefined"]},{"year":2021,"claim":"Dissected cell-type-specific in vivo roles and clarified NIK-IKK coupling, showing IKK-alpha in lymphatic endothelium drives lymph node formation while NIK can activate IKK2 independently of IKK1's enzymatic function.","evidence":"Tissue-specific conditional knockouts; NIK interaction-domain knock-in mice with co-IP and pathway assays","pmids":["34810256","41060807"],"confidence":"High","gaps":["Distinct effectors in LEC vs hematopoietic compartments unidentified","Structural basis of NIK-IKK2 independent activation unresolved"]},{"year":2022,"claim":"Suggested post-translational regulation of IKK-alpha by O-GlcNAc-modified NLRX1 to limit IL-1beta in macrophages.","evidence":"Co-IP, colocalization, OGT inhibition, IL-1beta measurement","pmids":["35513753"],"confidence":"Low","gaps":["Single co-IP study without reciprocal validation","Direct effect of NLRX1 binding on IKK-alpha kinase activity not shown"]},{"year":null,"claim":"How nuclear IKK-alpha is selectively recruited to specific gene loci, and the molecular basis of its kinase-independent structural functions in development and ECM remodeling, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No defined targeting mechanism for nuclear/chromatin IKK-alpha","Kinase-independent effector partners largely unidentified","Full active-signalsome structure not determined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,2,4,10,35]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,2,4,16,27,35]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[4,6]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[13,19,24,27,30]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,5]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7,15,16,27,30,31]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2,5,8,33]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,11,23,27,39]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[9,14,19,25,28,39]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[16,27,30]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[23,30,38]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[31,36]}],"complexes":["IKK signalsome"],"partners":["IKBKB","NEMO","MAP3K14","VAV1","SMAD3","DDX3X","RELB","NFKB2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O15111","full_name":"Inhibitor of nuclear factor kappa-B kinase subunit alpha","aliases":["Conserved helix-loop-helix ubiquitous kinase","I-kappa-B kinase 1","IKK-1","IKK1","Nuclear factor NF-kappa-B inhibitor kinase alpha","NFKBIKA","Transcription factor 16","TCF-16"],"length_aa":745,"mass_kda":84.6,"function":"Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues (PubMed:18626576, PubMed:35952808, PubMed:9244310, PubMed:9252186, PubMed:9346484). These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11) (PubMed:21765415). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes (PubMed:20501937). In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Also participates in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities (PubMed:17434128). Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP (PubMed:12789342). Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor (PubMed:15084260). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates AMBRA1 following mitophagy induction, promoting AMBRA1 interaction with ATG8 family proteins and its mitophagic activity (PubMed:30217973)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/O15111/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CHUK","classification":"Not Classified","n_dependent_lines":60,"n_total_lines":1208,"dependency_fraction":0.04966887417218543},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000213341","cell_line_id":"CID001905","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":2}],"interactors":[{"gene":"IKBKB","stoichiometry":10.0},{"gene":"IKBKG","stoichiometry":10.0},{"gene":"CDC37","stoichiometry":0.2},{"gene":"CPSF6","stoichiometry":0.2},{"gene":"FKBP5","stoichiometry":0.2},{"gene":"NFKB1","stoichiometry":0.2},{"gene":"RELA","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001905","total_profiled":1310},"omim":[{"mim_id":"620491","title":"MATURIN, NEURAL PROGENITOR DIFFERENTIATION REGULATOR HOMOLOG; MTURN","url":"https://www.omim.org/entry/620491"},{"mim_id":"620449","title":"IMMUNODEFICIENCY 112; IMD112","url":"https://www.omim.org/entry/620449"},{"mim_id":"619339","title":"BARTSOCAS-PAPAS SYNDROME 2; BPS2","url":"https://www.omim.org/entry/619339"},{"mim_id":"617464","title":"UNC5 FAMILY C-TERMINAL-LIKE PROTEIN; UNC5CL","url":"https://www.omim.org/entry/617464"},{"mim_id":"615700","title":"PYRIN DOMAIN-CONTAINING PROTEIN 1; PYDC1","url":"https://www.omim.org/entry/615700"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CHUK"},"hgnc":{"alias_symbol":["IKK1","IKK-alpha","IkBKA","NFKBIKA","IKKA"],"prev_symbol":["TCF16"]},"alphafold":{"accession":"O15111","domains":[{"cath_id":"3.30.200.20","chopping":"2-98","consensus_level":"medium","plddt":80.1208,"start":2,"end":98},{"cath_id":"1.10.510.10","chopping":"99-171_185-311","consensus_level":"medium","plddt":91.3381,"start":99,"end":311},{"cath_id":"3.10.20.90","chopping":"313-392","consensus_level":"high","plddt":93.9941,"start":313,"end":392},{"cath_id":"1.20.1270.250","chopping":"419-619","consensus_level":"high","plddt":91.33,"start":419,"end":619}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O15111","model_url":"https://alphafold.ebi.ac.uk/files/AF-O15111-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O15111-F1-predicted_aligned_error_v6.png","plddt_mean":83.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CHUK","jax_strain_url":"https://www.jax.org/strain/search?query=CHUK"},"sequence":{"accession":"O15111","fasta_url":"https://rest.uniprot.org/uniprotkb/O15111.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O15111/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O15111"}},"corpus_meta":[{"pmid":"9346484","id":"PMC_9346484","title":"IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.","date":"1997","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9346484","citation_count":1786,"is_preprint":false},{"pmid":"9520446","id":"PMC_9520446","title":"NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9520446","citation_count":451,"is_preprint":false},{"pmid":"22660635","id":"PMC_22660635","title":"The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.","date":"2012","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22660635","citation_count":372,"is_preprint":false},{"pmid":"15489227","id":"PMC_15489227","title":"Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15489227","citation_count":317,"is_preprint":false},{"pmid":"11438700","id":"PMC_11438700","title":"Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11438700","citation_count":228,"is_preprint":false},{"pmid":"15897281","id":"PMC_15897281","title":"I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15897281","citation_count":209,"is_preprint":false},{"pmid":"26948423","id":"PMC_26948423","title":"TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway.","date":"2016","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26948423","citation_count":170,"is_preprint":false},{"pmid":"23708292","id":"PMC_23708292","title":"Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly.","date":"2013","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23708292","citation_count":158,"is_preprint":false},{"pmid":"10898787","id":"PMC_10898787","title":"Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation.","date":"2000","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10898787","citation_count":155,"is_preprint":false},{"pmid":"9804806","id":"PMC_9804806","title":"Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9804806","citation_count":153,"is_preprint":false},{"pmid":"14691250","id":"PMC_14691250","title":"Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14691250","citation_count":146,"is_preprint":false},{"pmid":"20386985","id":"PMC_20386985","title":"Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.","date":"2010","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/20386985","citation_count":122,"is_preprint":false},{"pmid":"21081648","id":"PMC_21081648","title":"IKK(α) controls canonical TGF(ß)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells.","date":"2010","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/21081648","citation_count":111,"is_preprint":false},{"pmid":"17093266","id":"PMC_17093266","title":"p63 is upstream of IKK alpha in epidermal development.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17093266","citation_count":110,"is_preprint":false},{"pmid":"16116086","id":"PMC_16116086","title":"Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1).","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16116086","citation_count":108,"is_preprint":false},{"pmid":"20855622","id":"PMC_20855622","title":"The Listeria monocytogenes InlC protein interferes with innate immune responses by targeting the I{kappa}B kinase subunit IKK{alpha}.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20855622","citation_count":93,"is_preprint":false},{"pmid":"18606991","id":"PMC_18606991","title":"IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18606991","citation_count":79,"is_preprint":false},{"pmid":"17351639","id":"PMC_17351639","title":"Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation.","date":"2007","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17351639","citation_count":77,"is_preprint":false},{"pmid":"18239189","id":"PMC_18239189","title":"IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung.","date":"2008","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18239189","citation_count":75,"is_preprint":false},{"pmid":"18713867","id":"PMC_18713867","title":"BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18713867","citation_count":74,"is_preprint":false},{"pmid":"8777433","id":"PMC_8777433","title":"CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain.","date":"1995","source":"Cellular & molecular biology research","url":"https://pubmed.ncbi.nlm.nih.gov/8777433","citation_count":68,"is_preprint":false},{"pmid":"30347849","id":"PMC_30347849","title":"Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets.","date":"2018","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/30347849","citation_count":66,"is_preprint":false},{"pmid":"17237423","id":"PMC_17237423","title":"A novel role for IkappaB kinase (IKK) alpha and IKKbeta in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17237423","citation_count":65,"is_preprint":false},{"pmid":"14960276","id":"PMC_14960276","title":"A dual role for Ikk alpha in tooth development.","date":"2004","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/14960276","citation_count":63,"is_preprint":false},{"pmid":"16687566","id":"PMC_16687566","title":"Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16687566","citation_count":60,"is_preprint":false},{"pmid":"25740981","id":"PMC_25740981","title":"Dynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus Infection.","date":"2015","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/25740981","citation_count":60,"is_preprint":false},{"pmid":"10823818","id":"PMC_10823818","title":"Characterization of the recombinant IKK1/IKK2 heterodimer. Mechanisms regulating kinase activity.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10823818","citation_count":57,"is_preprint":false},{"pmid":"17502144","id":"PMC_17502144","title":"The discovery of 2-amino-3,5-diarylbenzamide inhibitors of IKK-alpha and IKK-beta kinases.","date":"2007","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/17502144","citation_count":55,"is_preprint":false},{"pmid":"20961246","id":"PMC_20961246","title":"Mutant CHUK and severe fetal encasement malformation.","date":"2010","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20961246","citation_count":53,"is_preprint":false},{"pmid":"20692251","id":"PMC_20692251","title":"poky/chuk/ikk1 is required for differentiation of the zebrafish embryonic epidermis.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20692251","citation_count":53,"is_preprint":false},{"pmid":"27851956","id":"PMC_27851956","title":"Structural Basis for the Activation of IKK1/α.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27851956","citation_count":50,"is_preprint":false},{"pmid":"17700524","id":"PMC_17700524","title":"ATM-dependent nuclear accumulation of IKK-alpha plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17700524","citation_count":48,"is_preprint":false},{"pmid":"18321726","id":"PMC_18321726","title":"New role of IKK alpha/beta phosphorylated I kappa B alpha in axon outgrowth and axon initial segment development.","date":"2008","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/18321726","citation_count":46,"is_preprint":false},{"pmid":"21402739","id":"PMC_21402739","title":"Transcriptional regulation of the Th17 immune response by IKK(alpha).","date":"2011","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21402739","citation_count":46,"is_preprint":false},{"pmid":"23477746","id":"PMC_23477746","title":"The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study.","date":"2013","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/23477746","citation_count":43,"is_preprint":false},{"pmid":"12626540","id":"PMC_12626540","title":"Vav-1 and the IKK alpha subunit of I kappa B kinase functionally associate to induce NF-kappa B activation in response to CD28 engagement.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12626540","citation_count":43,"is_preprint":false},{"pmid":"24023802","id":"PMC_24023802","title":"IKKα/CHUK regulates extracellular matrix remodeling independent of its kinase activity to facilitate articular chondrocyte differentiation.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24023802","citation_count":42,"is_preprint":false},{"pmid":"10523828","id":"PMC_10523828","title":"Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IkappaB kinases (IKK-alpha/beta) and IKK-beta is a developmentally regulated protein kinase.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10523828","citation_count":40,"is_preprint":false},{"pmid":"16407216","id":"PMC_16407216","title":"IKK alpha regulates estrogen-induced cell cycle progression by modulating E2F1 expression.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16407216","citation_count":37,"is_preprint":false},{"pmid":"33808757","id":"PMC_33808757","title":"Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33808757","citation_count":36,"is_preprint":false},{"pmid":"18068231","id":"PMC_18068231","title":"Differential regulation of IKK alpha-mediated activation of IRF3/7 by NIK.","date":"2007","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18068231","citation_count":35,"is_preprint":false},{"pmid":"27678221","id":"PMC_27678221","title":"The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100.","date":"2016","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/27678221","citation_count":27,"is_preprint":false},{"pmid":"30463064","id":"PMC_30463064","title":"miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30463064","citation_count":25,"is_preprint":false},{"pmid":"7558004","id":"PMC_7558004","title":"CHUK, a conserved helix-loop-helix ubiquitous kinase, maps to human chromosome 10 and mouse chromosome 19.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7558004","citation_count":24,"is_preprint":false},{"pmid":"29550635","id":"PMC_29550635","title":"Participation of the IKK-α/β complex in the inhibition of the TNF-α/NF-κB pathway by glycine: Possible involvement of a membrane receptor specific to adipocytes.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29550635","citation_count":24,"is_preprint":false},{"pmid":"16474991","id":"PMC_16474991","title":"Neuroprotective effect of a chuk-me-sun-dan on neurons from ischemic damage and neuronal cell toxicity.","date":"2006","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/16474991","citation_count":22,"is_preprint":false},{"pmid":"30291224","id":"PMC_30291224","title":"IL-17A-associated IKK-α signaling induced TSLP production in epithelial cells of COPD patients.","date":"2018","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30291224","citation_count":21,"is_preprint":false},{"pmid":"32627230","id":"PMC_32627230","title":"Cantharidin-induced acute hepatotoxicity: the role of TNF-α, IKK-α, Bcl-2, Bax and caspase3.","date":"2020","source":"Journal of applied toxicology : JAT","url":"https://pubmed.ncbi.nlm.nih.gov/32627230","citation_count":20,"is_preprint":false},{"pmid":"33768100","id":"PMC_33768100","title":"D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-α/NF-κB p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis.","date":"2021","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33768100","citation_count":20,"is_preprint":false},{"pmid":"16984773","id":"PMC_16984773","title":"Use of Chuk as an internal standard suitable for quantitative RT-PCR in mouse preimplantation embryos.","date":"2006","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/16984773","citation_count":19,"is_preprint":false},{"pmid":"24556686","id":"PMC_24556686","title":"Survivin-2B promotes autophagy by accumulating IKK alpha in the nucleus of selenite-treated NB4 cells.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24556686","citation_count":19,"is_preprint":false},{"pmid":"24215713","id":"PMC_24215713","title":"Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24215713","citation_count":18,"is_preprint":false},{"pmid":"31222033","id":"PMC_31222033","title":"Inducible knockout of CHUK/IKKα in adult chondrocytes reduces progression of cartilage degradation in a surgical model of osteoarthritis.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31222033","citation_count":15,"is_preprint":false},{"pmid":"31173238","id":"PMC_31173238","title":"miR‑379 inhibits cell proliferation and epithelial‑mesenchymal transition by targeting CHUK through the NF‑κB pathway in non‑small cell lung cancer.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/31173238","citation_count":14,"is_preprint":false},{"pmid":"12459277","id":"PMC_12459277","title":"Characterization of the bovine IkappaB kinases (IKK)alpha and IKKbeta, the regulatory subunit NEMO and their substrate IkappaBalpha.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12459277","citation_count":14,"is_preprint":false},{"pmid":"10593898","id":"PMC_10593898","title":"Peptides corresponding to the N and C termini of IkappaB-alpha, -beta, and -epsilon as probes of the two catalytic subunits of IkappaB kinase, IKK-1 and IKK-2.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10593898","citation_count":13,"is_preprint":false},{"pmid":"29630899","id":"PMC_29630899","title":"IKK1/2 protect human cells from TNF-mediated RIPK1-dependent apoptosis in an NF-κB-independent manner.","date":"2018","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29630899","citation_count":12,"is_preprint":false},{"pmid":"31419940","id":"PMC_31419940","title":"Polymorphisms and genetic effects of PRLR, MOGAT1, MINPP1 and CHUK genes on milk fatty acid traits in Chinese Holstein.","date":"2019","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31419940","citation_count":12,"is_preprint":false},{"pmid":"35796880","id":"PMC_35796880","title":"The long non-coding RNA SNHG1 attenuates chondrocyte apoptosis and inflammation via the miR-195/IKK-α axis.","date":"2022","source":"Cell and tissue banking","url":"https://pubmed.ncbi.nlm.nih.gov/35796880","citation_count":12,"is_preprint":false},{"pmid":"31792060","id":"PMC_31792060","title":"CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation.","date":"2019","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/31792060","citation_count":9,"is_preprint":false},{"pmid":"35422814","id":"PMC_35422814","title":"Scallop IKK1 Responds to Bacterial and Virus-Related Pathogen Stimulation and Interacts With MyD88 Adaptor of Toll-Like Receptor Pathway Signaling.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35422814","citation_count":9,"is_preprint":false},{"pmid":"28513979","id":"PMC_28513979","title":"Identification of a de novo variant in CHUK in a patient with an EEC/AEC syndrome-like phenotype and hypogammaglobulinemia.","date":"2017","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/28513979","citation_count":9,"is_preprint":false},{"pmid":"38775480","id":"PMC_38775480","title":"GRP78 recognizes EV-F 3D protein and activates NF-κB to repress virus replication by interacting with CHUK/IKBKB.","date":"2024","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/38775480","citation_count":8,"is_preprint":false},{"pmid":"33688203","id":"PMC_33688203","title":"MiRNA-223-3p Affects Mantle Cell Lymphoma Development by Regulating the CHUK/NF-ƘB2 Signaling Pathway.","date":"2021","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33688203","citation_count":8,"is_preprint":false},{"pmid":"22833419","id":"PMC_22833419","title":"Knockdown of IKK1/2 promotes differentiation of mouse embryonic stem cells into neuroectoderm at the expense of mesoderm.","date":"2012","source":"Stem cell reviews and reports","url":"https://pubmed.ncbi.nlm.nih.gov/22833419","citation_count":8,"is_preprint":false},{"pmid":"29958295","id":"PMC_29958295","title":"The NEDD8 E3 ligase DCNL5 is phosphorylated by IKK alpha during Toll-like receptor activation.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29958295","citation_count":8,"is_preprint":false},{"pmid":"34474146","id":"PMC_34474146","title":"miRNA-223-3p modulates ibrutinib resistance through regulation of the CHUK/Nf-κb signaling pathway in mantle cell lymphoma.","date":"2021","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/34474146","citation_count":7,"is_preprint":false},{"pmid":"21435444","id":"PMC_21435444","title":"IKK1 control of epidermal differentiation is modulated by notch signaling.","date":"2011","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21435444","citation_count":7,"is_preprint":false},{"pmid":"12054687","id":"PMC_12054687","title":"The catalytic subunits of IkappaB kinase, IKK-1 and IKK-2, contain non-equivalent active sites when expressed as homodimers.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12054687","citation_count":7,"is_preprint":false},{"pmid":"29523099","id":"PMC_29523099","title":"Novel heterozygous pathogenic variants in CHUK in a patient with AEC-like phenotype, immune deficiencies and 1q21.1 microdeletion syndrome: a case report.","date":"2018","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29523099","citation_count":7,"is_preprint":false},{"pmid":"37074502","id":"PMC_37074502","title":"IKK1 aggravates ischemia-reperfusion kidney injury by promoting the differentiation of effector T cells.","date":"2023","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/37074502","citation_count":6,"is_preprint":false},{"pmid":"16237959","id":"PMC_16237959","title":"Neuroprotective effect of Chuk-Me-Sun-Dan on NMDA- and AMPA-evoked nitric oxide synthase activity in mouse brain.","date":"2005","source":"Immunopharmacology and immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/16237959","citation_count":6,"is_preprint":false},{"pmid":"35513753","id":"PMC_35513753","title":"The interaction of O-GlcNAc-modified NLRX1 and IKK-α modulates IL-1β expression in M1 macrophages.","date":"2022","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/35513753","citation_count":6,"is_preprint":false},{"pmid":"11698579","id":"PMC_11698579","title":"IKK alpha on center stage.","date":"2001","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/11698579","citation_count":6,"is_preprint":false},{"pmid":"36113632","id":"PMC_36113632","title":"ATM/IKK alpha axis regulates the crosstalk between autophagy and apoptosis in selenite-treated Jurkat cells.","date":"2022","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/36113632","citation_count":5,"is_preprint":false},{"pmid":"33992196","id":"PMC_33992196","title":"Association of CHUK gene polymorphism and ischemic stroke in the Han Chinese population.","date":"2021","source":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia","url":"https://pubmed.ncbi.nlm.nih.gov/33992196","citation_count":4,"is_preprint":false},{"pmid":"35173303","id":"PMC_35173303","title":"Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancer.","date":"2022","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35173303","citation_count":4,"is_preprint":false},{"pmid":"24219383","id":"PMC_24219383","title":"Silencing of the cell cycle checkpoint gene 14-3-3σ in basal cell carcinomas correlates with reduced expression of IKK-α.","date":"2013","source":"Journal of the European Academy of Dermatology and Venereology : JEADV","url":"https://pubmed.ncbi.nlm.nih.gov/24219383","citation_count":4,"is_preprint":false},{"pmid":"40370804","id":"PMC_40370804","title":"Delivery of miR-26a-5p by Subcutaneous Adipose Tissue-Derived Extracellular Vesicles Alleviates Acute Lung Injury in Mice Through CHUK/NF-κB Pathway.","date":"2025","source":"International journal of nanomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/40370804","citation_count":3,"is_preprint":false},{"pmid":"24523631","id":"PMC_24523631","title":"RNAi-mediated knockdown of IKK1 in transgenic mice using a transgenic construct containing the human H1 promoter.","date":"2014","source":"TheScientificWorldJournal","url":"https://pubmed.ncbi.nlm.nih.gov/24523631","citation_count":3,"is_preprint":false},{"pmid":"23157456","id":"PMC_23157456","title":"Models for predicting IKKA and IKKB blockade.","date":"2012","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/23157456","citation_count":3,"is_preprint":false},{"pmid":"34810256","id":"PMC_34810256","title":"Lymph node formation and B cell homeostasis require IKK-α in distinct endothelial cell-derived compartments.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34810256","citation_count":2,"is_preprint":false},{"pmid":"33527006","id":"PMC_33527006","title":"A naturally derived small molecule NDSM253 inhibits IKK1 to suppress inflammation response and promote bone healing after fracture.","date":"2021","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/33527006","citation_count":2,"is_preprint":false},{"pmid":"30451218","id":"PMC_30451218","title":"A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α.","date":"2018","source":"Journal of visualized experiments : JoVE","url":"https://pubmed.ncbi.nlm.nih.gov/30451218","citation_count":1,"is_preprint":false},{"pmid":"38847220","id":"PMC_38847220","title":"Higher expression of BRCA1, and CHUK and lower expression of NFKBIA, ESR1, PIK3R1, and PPARG in HAM/TSP compared to ATLL, a diverse pathological consequence.","date":"2024","source":"Indian journal of pathology & microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/38847220","citation_count":1,"is_preprint":false},{"pmid":"34236638","id":"PMC_34236638","title":"A Kinase Assay for Measuring the Activity of the NIK-IKK1 Complex Induced via the Noncanonical NF-κB Pathway.","date":"2021","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/34236638","citation_count":1,"is_preprint":false},{"pmid":"40151361","id":"PMC_40151361","title":"Assessment of Unexpected (Non-ABO) Red Blood Cell Antibodies and Their Associated Clinical Conditions Among Patients and Blood Donors Attending University Teaching Hospital of Kigali (CHUK) and Rwanda Blood Transfusion Division.","date":"2025","source":"Advances in hematology","url":"https://pubmed.ncbi.nlm.nih.gov/40151361","citation_count":1,"is_preprint":false},{"pmid":"18973019","id":"PMC_18973019","title":"[Effect of Kuijieling decoction on proteins expression of IKK-alpha in colonic mucosa of ulcerative colitis model rats].","date":"2008","source":"Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials","url":"https://pubmed.ncbi.nlm.nih.gov/18973019","citation_count":1,"is_preprint":false},{"pmid":"39062574","id":"PMC_39062574","title":"Cimicifugoside H-2 as an Inhibitor of IKK1/Alpha: A Molecular Docking and Dynamic Simulation Study.","date":"2024","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39062574","citation_count":0,"is_preprint":false},{"pmid":"41060807","id":"PMC_41060807","title":"Limited activation interdependence and differing patterns of the in vivo effects of IKK1 and IKK2 downstream of NIK.","date":"2025","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/41060807","citation_count":0,"is_preprint":false},{"pmid":"42135680","id":"PMC_42135680","title":"Hsa-miR-5585-3p regulates the NLRP3 activation and the expression of cytokines through CHUK in a cellular model of diabetic kidney disease.","date":"2026","source":"BMC endocrine disorders","url":"https://pubmed.ncbi.nlm.nih.gov/42135680","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.01.17.25320742","title":"Rare variants in PRKCI cause Van der Woude syndrome and other features of peridermopathy","date":"2025-01-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.17.25320742","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48820,"output_tokens":10340,"usd":0.15078,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20795,"output_tokens":7035,"usd":0.139925,"stage2_stop_reason":"end_turn"},"total_usd":0.290705,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"CHUK (IKK-alpha) was identified as a new protein containing a serine-threonine kinase catalytic domain at the N-terminus, a leucine zipper-like amphipathic alpha-helix in the middle, and a helix-loop-helix domain at the C-terminus, suggesting its kinase activity may be targeted to HLH and/or leucine zipper transcription factors.\",\n      \"method\": \"cDNA cloning and sequence analysis of murine CHUK\",\n      \"journal\": \"Cellular & molecular biology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — original cloning and domain architecture identification; structural inference from sequence, not functional reconstitution\",\n      \"pmids\": [\"8777433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"IKK-1 (IKK-alpha) and IKK-2 are components of a large multiprotein IkappaB kinase (IKK) signalsome complex purified from HeLa cells that phosphorylates IkappaB-alpha and IkappaB-beta in response to cytokine stimulation. Mutant IKK-2 affected RelA nuclear translocation and NF-kappaB-dependent reporter activity, establishing both kinases as essential for NF-kappaB activation.\",\n      \"method\": \"Biochemical purification of the IKK complex from HeLa cells, in vitro kinase assays phosphorylating IkappaB substrates, dominant-negative mutant analysis of NF-kappaB reporter activity\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution with in vitro kinase assay plus functional validation with dominant-negative mutants; foundational study widely replicated\",\n      \"pmids\": [\"9346484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"NF-kappaB-inducing kinase (NIK) preferentially phosphorylates IKK-alpha over IKK-beta specifically on Ser-176 in the activation loop. A Ser-176-to-Ala mutant cannot be phosphorylated or activated by NIK and acts as a dominant negative inhibitor of IL-1- and TNF-induced NF-kappaB activation; a Ser-176-to-Glu mutant is constitutively active.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis (S176A and S176E), dominant-negative inhibition of NF-kappaB activation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus mutagenesis with gain-of-function and loss-of-function alleles, rigorous mechanistic study\",\n      \"pmids\": [\"9520446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Both IKK-alpha and IKK-beta are activated by hematopoietic progenitor kinase-1 (HPK1) and MEKK1 stress response kinases. IKK-beta phosphorylated IkappaB constitutively in these assays whereas IKK-alpha was not active in the absence of cell stimulation, indicating differential basal activity.\",\n      \"method\": \"In vitro kinase assays, overexpression of HPK1 and MEKK1 upstream activators\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase assays with defined upstream activators, single lab\",\n      \"pmids\": [\"10523828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"IKK-1 (IKK-alpha) homodimer has dramatically lower catalytic efficiency toward IkappaB-alpha peptide substrates (k(cat)/K(m) ~0.02 h-1 uM-1) compared to IKK-2 (17.44 h-1 uM-1), while the IKK1/IKK2 heterodimer exhibits the highest catalytic efficiency (47.50 h-1 uM-1). The C-terminus of IkappaB-alpha activates the multisubunit IKK complex through subunits other than IKK-2.\",\n      \"method\": \"Recombinant protein expression (baculovirus), purification, and kinetic analysis of homodimers vs. heterodimer; peptide substrate kinetics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — rigorous in vitro reconstitution and kinetic characterization of purified recombinant IKK isoforms with multiple substrates and mutagenesis\",\n      \"pmids\": [\"10823818\", \"10593898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"IKK1 and IKK2 double-knockout mouse embryo fibroblasts completely lack NF-kappaB activity in response to all tested inducers, and double-deficient embryos lose NF-kappaB-lacZ reporter expression in vascular endothelial cells, establishing that IKK1 and IKK2 are together essential for NF-kappaB activation in vivo.\",\n      \"method\": \"Genetic knockout (IKK1-/- / IKK2-/- double-deficient mice), NF-kappaB reporter (kappaB-lacZ transgene), MEF stimulation assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double genetic knockout with multiple in vivo and in vitro NF-kappaB readouts\",\n      \"pmids\": [\"10898787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"IKK-alpha homodimers contain non-equivalent active sites: ADP and a peptide inhibitor show differential potency against IkappaBalpha phosphorylation vs. autophosphorylation reactions. The phosphorylation state of the activation loop (S176/S180) affects active site conformation, and autophosphorylation within the homodimer is intramolecular.\",\n      \"method\": \"Recombinant baculovirus-expressed homodimers, enzyme kinetics, inhibitor analysis, S176E/S180E mutant comparison\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic analysis with mutagenesis; single lab, mechanistically detailed\",\n      \"pmids\": [\"12054687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Vav-1 constitutively associates with IKK-alpha (but not IKK-beta) in Jurkat and primary CD4+ T cells via their helix-loop-helix domains. CD28 engagement increases Vav-1-associated IKK-alpha kinase activity, and both IKK-alpha and Vav-1 augment CD28-induced NF-kappaB activation. Vav-1 and IKK-alpha (but not IKK-beta) colocalize at the membrane upon CD28 stimulation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, NF-kappaB reporter assay, confocal microscopy\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, kinase activity assay, and imaging in the same study; single lab\",\n      \"pmids\": [\"12626540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"EBV LMP1 induces p100/NF-kappaB2 processing to p52 in human lymphoblasts via a NIK/IKKalpha-dependent and IKKbeta/IKKgamma-independent mechanism. IKKalpha knockout MEFs show loss of LMP1-induced MIG and CXCR4 upregulation, while IKKalpha absence hyperinduces MIP-2, TNF-alpha, and I-TAC, indicating IKKalpha's dual role in promoting noncanonical and downmodulating canonical NF-kappaB signaling.\",\n      \"method\": \"Genetic knockout MEFs (IKKalpha KO), dominant-negative IKK constructs, RNA expression analysis, NF-kappaB pathway dissection\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout cells with multiple NF-kappaB pathway readouts, pathway placement by epistasis\",\n      \"pmids\": [\"14691250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"IKK-alpha has a dual NF-kappaB-dependent role (cusp formation) and an NF-kappaB-independent role (direction of epithelial invagination vs. evagination in incisor and whisker development) in tooth and ectodermal appendage development in mice.\",\n      \"method\": \"Ikkα mutant mouse analysis, genetic comparison with cIκBαΔN transgenic mice (NF-kappaB blocking), examination of Notch/Wnt/Shh pathway markers\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis using two distinct mouse models with clear phenotypic readouts separating NF-kappaB-dependent from independent functions\",\n      \"pmids\": [\"14960276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"IKKalpha, IKKbeta, IKKepsilon, and TBK1 can all phosphorylate p65/RelA at Ser-536. IKKepsilon and TBK1 phosphorylate Ser-536 in vivo and in vitro. Importantly, IKKalpha/beta RNAi knockdown or IKKbeta inhibitor alone could not suppress Ser-536 phosphorylation, suggesting IKK-independent pathways also contribute.\",\n      \"method\": \"RNA interference, pharmacological inhibitors, chromatographic fractionation, in vitro kinase assay, reconstitution in p65-deficient fibroblasts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal methods but complex multi-kinase picture; single lab\",\n      \"pmids\": [\"15489227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"IKK1 (IKKalpha) knockout macrophages show enhanced NF-kappaB activity due to prolonged IkappaBalpha degradation after pathogen stimulation, caused by uncontrolled IKK2 kinase activity. This reveals IKK1 functions as a checkpoint to control IKK2-mediated IkappaBalpha phosphorylation in innate immunity.\",\n      \"method\": \"IKK1-/- embryonic liver-derived macrophages, NF-kappaB activity assay, IKK2 kinase assay, cytokine secretion measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout macrophages with multiple functional readouts and mechanistic pathway placement\",\n      \"pmids\": [\"16116086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"IKKalpha is required for RANK ligand-induced osteoclast formation in vitro but is not required in vivo for osteoclastogenesis, while IKKbeta is required both in vitro and in vivo. This establishes distinct and non-redundant roles for IKKalpha and IKKbeta downstream of RANK signaling.\",\n      \"method\": \"Conditional knockout mice (hematopoietic-specific), in vitro osteoclastogenesis assays, inflammation-induced bone loss model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in vivo and in vitro with two different conditional knockouts\",\n      \"pmids\": [\"15897281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"IKKalpha regulates estrogen-induced cell cycle progression by controlling transcription of the E2F1 gene and E2F1-responsive genes. Estrogen treatment increases association of endogenous IKKalpha with E2F1 on E2F1-bound promoters, and IKKalpha potentiates p300/CBP-associated factor-mediated acetylation of E2F1.\",\n      \"method\": \"siRNA knockdown of IKKalpha, chromatin immunoprecipitation, Co-immunoprecipitation, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and co-IP with functional readout; single lab\",\n      \"pmids\": [\"16407216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"p63 (TAp63 isoform) directly and indirectly transactivates IKKalpha and Ets-1, respectively, in a genetic pathway upstream of IKKalpha during epidermal development. DeltaNp63 upregulates IKKalpha indirectly through GATA-3. Genetic complementation in mice confirmed this p63→IKKalpha epistatic relationship.\",\n      \"method\": \"Molecular analyses (transcriptional assays), genetic complementation in mice, in vivo epistasis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis established by in vivo complementation combined with molecular mechanistic analysis\",\n      \"pmids\": [\"17093266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ATM kinase phosphorylates IKK-alpha at Ser-473 in response to cisplatin treatment, causing nuclear accumulation of IKK-alpha, which then stabilizes p73 to promote apoptosis. IKKalpha-deficient MEFs show cisplatin-resistant phenotype.\",\n      \"method\": \"In vitro kinase assay (ATM phosphorylates IKK-alpha), site identification, immunofluorescence colocalization, IKKalpha-deficient MEF functional assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay identifying phosphorylation site plus loss-of-function phenotype; single lab\",\n      \"pmids\": [\"17700524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IKK-alpha mediates chromatin modification on pro-inflammatory gene promoters in response to cigarette smoke: it phosphorylates histone H3 Ser-10 and promotes acetylation of H3 Lys-9 and RelA/p65 Lys-310, leading to sustained transcription of IL-6 and MIP-2. Dominant-negative IKK-alpha reduced CS-induced chromatin modification.\",\n      \"method\": \"Chromatin immunoprecipitation, gain-of-function overexpression, dominant-negative mutant transfection, in vivo mouse lung CS exposure\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with gain- and loss-of-function experiments; single lab, in vivo and in vitro\",\n      \"pmids\": [\"18239189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NIK differentially regulates IKK-alpha-mediated activation of IRF3/7 vs. NF-kappaB: IKKalpha-S176E constitutively activates IRF3/7, while IKKalpha-S180E loses the ability to activate IRF3/7, demonstrating that the two NIK-phosphorylation sites on IKKalpha differentially govern its downstream effector functions.\",\n      \"method\": \"Site-directed mutagenesis (S176E, S180E), overexpression, IFN-alpha promoter reporter assay, NF-kappaB reporter assay\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with functional readouts for two distinct downstream pathways; single lab\",\n      \"pmids\": [\"18068231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IKK1/IKKalpha and IKKbeta are both required for S. pneumoniae-induced MUC5AC mucin upregulation via an ERK1-dependent but IkappaBalpha-p65- and p100-p52-independent mechanism, revealing novel NF-kappaB-independent roles for IKKs in innate mucosal defense.\",\n      \"method\": \"Dominant-negative IKK constructs, siRNA knockdown, pathway inhibitors, ERK dependency assays, in vivo mouse model\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple loss-of-function approaches; single lab with in vivo confirmation\",\n      \"pmids\": [\"17237423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Keratinocyte-specific IKK1 ablation causes impaired epidermal-barrier function and increased transepidermal water loss due to defects in stratum corneum lipid composition and epidermal tight junctions, mediated by deregulation of retinoic acid receptor target genes. IKK1 is recruited to promoters of retinoic acid-regulated genes, indicating a role in RA-regulated transcription.\",\n      \"method\": \"Conditional knockout mice (keratinocyte-specific IKK1 ablation), barrier function assays, chromatin immunoprecipitation, retinoic acid-induced gene expression analysis\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional genetic knockout with ChIP and multiple functional readouts; rigorous mechanistic study\",\n      \"pmids\": [\"17351639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BAFF activates Akt and Erk in primary mouse B cells through BAFF-R in an IKK1-dependent manner, establishing IKK1 as a coordinator of multiple BAFF-R-mediated survival signaling pathways beyond NF-kappaB.\",\n      \"method\": \"IKK1 conditional knockout B cells, BAFF stimulation, Akt and Erk phosphorylation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic conditional knockout with defined signaling readouts in primary cells\",\n      \"pmids\": [\"18713867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Combined conditional ablation of IKK1 and IKK2 (but not each alone) in hepatocytes sensitizes the liver to LPS/TNF-induced failure, revealing redundancy in canonical NF-kappaB signaling. Additionally, combined ablation of IKK1+IKK2 or IKK1+NEMO causes spontaneous fatal cholangitis involving IKK1-specific functions affecting the bile-blood barrier, revealing a novel IKK1-specific function in bile duct integrity.\",\n      \"method\": \"Conditional double-knockout mice (liver-specific), in vivo LPS challenge, histopathology\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple conditional genetic knockout combinations dissecting redundant and specific functions in vivo\",\n      \"pmids\": [\"18606991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IKKalpha/beta-phosphorylated IkappaBalpha plays a role in axon outgrowth and axon initial segment (AIS) development in hippocampal neurons. Inhibition of IkappaBalpha phosphorylation by IKKs impedes axon outgrowth and impairs localization of ankyrin G and voltage-gated sodium channels at the AIS.\",\n      \"method\": \"Pharmacological inhibition of IKK kinase activity in cultured hippocampal neurons, immunofluorescence for AIS markers\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pharmacological inhibitor with imaging; does not cleanly separate IKK-alpha from IKK-beta contributions; single lab\",\n      \"pmids\": [\"18321726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The L. monocytogenes secreted protein InlC directly interacts with IKKalpha and impairs IkappaB phosphorylation and degradation normally induced by TNF-alpha, thus dampening host NF-kappaB-dependent innate immune responses during infection.\",\n      \"method\": \"Protein-protein interaction assay (direct binding), infection assays with WT vs. inlC-deletion mutant, cytokine measurement, mouse peritonitis model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding established, functional consequence demonstrated in vitro and in vivo with genetic deletion\",\n      \"pmids\": [\"20855622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"IKKalpha is necessary for TGFbeta-SMAD-mediated epithelial-mesenchymal transition (EMT) in Panc1 cells, independently of NF-kappaB. IKKalpha interacts with SMAD3 and controls SMAD complex formation on DNA to regulate transcription of SNAIL and SLUG genes.\",\n      \"method\": \"IKKalpha siRNA knockdown, Co-immunoprecipitation of IKKalpha with SMAD3, chromatin immunoprecipitation, gene expression analysis in Panc1 and MDA-MB231 cells\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with functional readout, replicated in two cell lines; single lab\",\n      \"pmids\": [\"21081648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Loss of CHUK (IKKalpha) causes a lethal autosomal recessive fetal syndrome with severe craniofacial and limb malformations in humans, confirming IKKalpha is essential for skin epidermis and ectodermal derivative development.\",\n      \"method\": \"Human genetics (identification of point mutation), candidate-gene analysis, gene-expression arrays in affected fetuses\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — human loss-of-function genetics establishing essential developmental role; no in vitro mechanistic reconstitution\",\n      \"pmids\": [\"20961246\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In zebrafish, the maternal effect gene poky/chuk/ikk1 is required for EVL differentiation via its kinase activity but not via its HLH domain, in contrast to the mouse where the HLH domain is important, demonstrating conservation of the requirement for Ikk1 in epidermal differentiation with divergent molecular mechanisms.\",\n      \"method\": \"Zebrafish genetic (poky mutant), kinase-dead and HLH-domain mutant rescue experiments, cell cycle and differentiation marker analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic model with domain-specific rescue experiments; single lab\",\n      \"pmids\": [\"20692251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nuclear IKKalpha is present in resting CD4+ T cells and upon Th17 differentiation selectively associates with the Il17a gene locus to promote histone H3 phosphorylation and transcriptional activation of IL-17a in an NF-kappaB-independent manner.\",\n      \"method\": \"Chromatin immunoprecipitation (IKKalpha at Il17a locus), non-activatable IKKalpha knock-in T cells, Th17 differentiation assay, histone modification analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP demonstrating direct chromatin occupancy, genetic non-activatable knockin with functional differentiation phenotype\",\n      \"pmids\": [\"21402739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"IKK1 inactivation in keratinocytes results in increased p63 expression and repression of Notch signaling. Forced expression of the Notch1 intracellular domain (NICD) partially rescues the differentiation defect of IKK1-/- keratinocytes, placing IKK1 upstream of Notch in epidermal differentiation.\",\n      \"method\": \"Ikk1 genetic inactivation in keratinocytes, NICD overexpression rescue, p63 RNAi knockdown, gene expression analysis\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic rescue experiment establishing pathway order; single lab\",\n      \"pmids\": [\"21435444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IKKalpha acts independent of its kinase activity to drive chondrocyte hypertrophic differentiation. IKKalpha positively modulates ECM remodeling via multiple downstream targets including MMP-10 and TIMP-3, to maintain maximal MMP-13 collagenase activity. Differentiation of IKKalpha-deficient chondrocytes was rescued by a kinase-dead IKKalpha mutant.\",\n      \"method\": \"Cre-lox conditional IKKalpha knockout chondrocytes, kinase-dead mutant rescue, mRNA profiling, immunoblotting, MMP activity assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with kinase-dead rescue establishing kinase-independent function, multiple orthogonal methods\",\n      \"pmids\": [\"24023802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"HCV via its 3' UTR interacts with DDX3X to activate IKK-alpha, which translocates to the nucleus and induces a CBP/p300-mediated transcriptional program involving SREBPs to upregulate lipogenic genes and enhance lipid droplet formation for viral assembly, independently of NF-kappaB.\",\n      \"method\": \"siRNA knockdown, chemical inhibitors of IKK-alpha, RNA-protein interaction, nuclear translocation assay, lipid droplet imaging, SREBP transcriptional assay\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods establishing a novel nuclear NF-kappaB-independent function with loss-of-function and mechanistic pathway dissection\",\n      \"pmids\": [\"23708292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Survivin-2B stabilizes IKK-alpha in the nucleus of NB4 cells; decreased survivin-2B leads to reduced nuclear IKK-alpha, which reduces P73 levels and consequently reduces UVRAG expression, switching protective autophagy to apoptosis.\",\n      \"method\": \"Co-immunoprecipitation (survivin-2B/IKK-alpha interaction in nucleus), nuclear fractionation, gene knockdown, in vivo tumor model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and functional pathway analysis; single lab with in vivo confirmation\",\n      \"pmids\": [\"24556686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Upon HCV infection, DDX3X and IKK-alpha redistribute to stress granules (SGs) upon interaction with the HCV 3' UTR. Subsequently, IKK-alpha translocates to the nucleus while DDX3X and SG proteins redistribute to lipid droplet surfaces. Multiple HCV nonstructural proteins colocalize with DDX3X near SGs and LDs.\",\n      \"method\": \"Systematic imaging (live cell and fixed), biochemical fractionation, co-immunoprecipitation, siRNA knockdown of DDX3X and SG components\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — imaging and biochemical methods; single lab confirming and extending prior findings\",\n      \"pmids\": [\"25740981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"X-ray crystal structure and cryo-EM structure of human IKK1 revealed dimeric and hexameric (trimer of dimers) forms. A surface critical for hexamer formation is essential for IKK1-dependent cellular p100-to-p52 processing (non-canonical NF-kappaB signaling), and this surface is divergent from IKK2, providing structural basis for distinct signaling by the two kinases.\",\n      \"method\": \"Single-particle cryo-EM, X-ray crystallography, mutagenesis of hexamer-forming surface, p100 processing assay in cells\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structural determination by two orthogonal methods (cryo-EM and X-ray) combined with functional mutagenesis validating the identified surface\",\n      \"pmids\": [\"27851956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RelB competes with the NIK:IKK1 complex for binding to a shared region of p100 within a transitional complex containing RelB, NIK, IKK1, and p100. This competition modulates the balance between p100 processing to p52 (generating active RelB:p52) and protection of p100 as part of the kappaBsome, controlling non-canonical NF-kappaB signaling output.\",\n      \"method\": \"Co-immunoprecipitation mapping interaction domains, p100 processing assays, analysis of kappaBsome formation\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP with functional p100 processing readout; single lab, mechanistically detailed\",\n      \"pmids\": [\"27678221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DCNL5 is directly phosphorylated by IKK-alpha (but not IKK-beta) on Ser-41 upon Toll-like receptor activation, identifying DCNL5 as a specific IKK-alpha substrate in innate immune signaling and the first DCNL member known to be regulated by kinase-mediated phosphorylation.\",\n      \"method\": \"In vitro kinase assay (IKKalpha vs. IKKbeta specificity), phosphorylation site mapping (S41), TLR stimulation assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with site identification and specificity determination; single lab\",\n      \"pmids\": [\"29958295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"IKK1/IKK2 double-deficient human cells (generated by CRISPR/Cas9n) show increased TNF-induced apoptosis mediated via RIPK1 in a predominantly apoptotic manner, independently of NF-kappaB RelA. Single IKK1 or IKK2 deficiency does not increase cell death, demonstrating a redundant, NF-kappaB-independent pro-survival function of the IKK complex.\",\n      \"method\": \"CRISPR/Cas9n knockout of IKK1, IKK2, IKK1/2 double, and RELA; caspase-3 activation, Annexin V binding, RIPK1 inhibition\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean CRISPR knockouts with multiple readouts; single lab\",\n      \"pmids\": [\"29630899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Inducible IKKalpha knockout in adult chondrocytes reduces cartilage degradation, collagenase activity, and hypertrophy-like features in the destabilization of medial meniscus (DMM) mouse model of post-traumatic OA, confirming an in vivo kinase-independent role for IKKalpha in OA-associated cartilage degradation.\",\n      \"method\": \"Tamoxifen-inducible conditional knockout (AcanCreERT2/+; IKKαf/f mice), DMM surgical OA model, histopathology, collagenase activity assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible conditional genetic knockout in adult tissue-specific cells with quantitative in vivo readouts\",\n      \"pmids\": [\"31222033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"IKKalpha/CHUK acts as a tumor suppressor in lung epithelial cells: its loss in AT-II cells increases lung adenoma number and size after chemical carcinogen treatment, and IKKalpha knockdown in human NSCLC lines enhances xenograft tumor growth associated with upregulation of activated HIF-1alpha under hypoxia.\",\n      \"method\": \"Tamoxifen-inducible conditional IKKalpha knockout in AT-II cells, urethane carcinogenesis model, human NSCLC xenografts, transcriptome profiling, HIF-1alpha protein analysis\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent in vivo cancer models with mechanistic validation via transcriptome profiling; single lab\",\n      \"pmids\": [\"31792060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IKK-alpha in lymphatic endothelial cells (LECs) is absolutely essential for lymph node formation, while IKK-alpha in hematopoietic cells (but not LECs) is required for mature B cell homeostasis. These two functions are mediated by distinct IKK-alpha-expressing cell populations.\",\n      \"method\": \"Tissue-specific conditional knockout mice (Tie2-cre, Cdh5-cre, LEC-specific Lyve1-cre, hematopoietic-specific), analysis of lymph node formation and B cell numbers\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple cell-type-specific conditional knockouts dissecting distinct physiological roles in vivo\",\n      \"pmids\": [\"34810256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NIK, by binding to IKK1, also associates with IKK2 and NEMO, allowing NIK to direct phosphorylation of IKK2 independently of IKK1's enzymatic function. IKK2 activation is maintained even when NIK's interaction with IKK1/NF-kappaB2 is compromised by specific NIK mutation, demonstrating that NIK-IKK1 and NIK-IKK2 activation pathways are not strictly coupled.\",\n      \"method\": \"NIK interaction-domain mutant knock-in mice, IKK1/IKK2 co-immunoprecipitation with NIK, NF-kappaB pathway activation assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knock-in mutation combined with co-IP and in vivo pathway analysis; single recent paper with rigorous genetic approach\",\n      \"pmids\": [\"41060807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"O-GlcNAc-modified NLRX1 interacts with IKK-alpha in M1 macrophages; elevated O-GlcNAcylation enhances the NLRX1/IKK-alpha interaction, and this enhanced interaction reduces IL-1beta expression, suggesting IKK-alpha is regulated by NLRX1 in a post-translational modification-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, confocal colocalization, ubiquitination assay, OGT inhibitor treatment, IL-1beta expression measurement\",\n      \"journal\": \"In vitro cellular & developmental biology. Animal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single co-IP study; indirect evidence for IKK-alpha functional regulation; single lab\",\n      \"pmids\": [\"35513753\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CHUK/IKK-alpha is a serine-threonine kinase and core component of the IKK signalsome that, when activated by upstream kinases such as NIK (via phosphorylation of Ser-176), phosphorylates IkappaB proteins to trigger NF-kappaB activation (primarily through the non-canonical pathway via p100-to-p52 processing), while also exerting kinase-independent roles in epidermal differentiation, chondrocyte hypertrophy, and ECM remodeling; nuclear IKK-alpha additionally functions as a chromatin-modifying kinase (phosphorylating histone H3 and RelA at specific residues) to regulate Th17, pro-inflammatory, and HCV-lipogenic transcriptional programs independently of canonical NF-kappaB; its structural basis involves a dimeric/hexameric architecture whose hexamer-forming surface specifically mediates non-canonical signaling; and it is placed downstream of p63 and upstream of Notch/Wnt/Shh in skin development, with distinct cell-type-specific (lymphatic endothelial, hematopoietic, chondrocyte, lung epithelial) functions established by conditional genetics.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CHUK/IKK-alpha is a serine-threonine kinase, identified by its N-terminal kinase domain plus central leucine-zipper and C-terminal helix-loop-helix domains [#0], that operates as a core catalytic subunit of the multiprotein IkappaB kinase (IKK) signalsome which phosphorylates IkappaB proteins to drive NF-kappaB activation [#1]. IKK-alpha is activated through phosphorylation of its activation-loop residue Ser-176 by NIK and by stress kinases such as HPK1/MEKK1, with an S176E substitution rendering it constitutively active [#2, #3]; in vitro the IKK-alpha homodimer is a comparatively weak kinase while the IKK-alpha/IKK-beta heterodimer is most efficient toward IkappaB-alpha [#4], and the two kinases are together essential for NF-kappaB activation in vivo [#5]. A defining feature of IKK-alpha is its selective control of the non-canonical pathway, mediating NIK-dependent p100-to-p52 processing [#8] through a hexamer-forming surface, divergent from IKK-beta, that structural analysis shows is required for p100 processing [#33], with RelB competing for p100 to set signaling output [#34]; reciprocally, IKK-alpha restrains canonical IKK-beta-driven IkappaB-alpha degradation as an innate-immunity checkpoint [#11]. Beyond cytoplasmic kinase activity, nuclear IKK-alpha acts as a chromatin-modifying kinase, phosphorylating histone H3 and modulating RelA acetylation to sustain pro-inflammatory transcription [#16, #27], and is exploited by HCV—via DDX3X and the viral 3' UTR—to drive an SREBP/CBP-p300 lipogenic program independently of NF-kappaB [#30]. IKK-alpha additionally performs kinase-independent developmental and structural roles, including epidermal barrier formation via retinoic-acid-regulated transcription [#19], placement downstream of p63 and upstream of Notch in keratinocyte differentiation [#14, #28], and chondrocyte hypertrophy and ECM remodeling rescued by kinase-dead protein [#29, #37]. Distinct cell-type-specific in vivo functions—lymphatic endothelial cells for lymph node formation, hematopoietic cells for B cell homeostasis—have been established by conditional genetics [#39], and IKK-alpha behaves as a lung epithelial tumor suppressor whose loss promotes adenoma growth and HIF-1alpha accumulation [#38]. In humans, biallelic loss of CHUK causes a lethal autosomal recessive fetal syndrome with severe craniofacial and limb malformations [#25].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established the protein's existence and domain architecture, predicting that a kinase carrying leucine-zipper and HLH motifs might target transcription factors.\",\n      \"evidence\": \"cDNA cloning and sequence analysis of murine CHUK\",\n      \"pmids\": [\"8777433\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional kinase substrate identified\", \"No demonstration of complex membership or signaling role\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Placed IKK-alpha within the cytokine-responsive IKK signalsome and showed it phosphorylates IkappaB substrates, answering what the kinase does in NF-kappaB signaling.\",\n      \"evidence\": \"Biochemical purification of the IKK complex from HeLa cells, in vitro kinase assays, dominant-negative analysis\",\n      \"pmids\": [\"9346484\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of IKK-alpha vs IKK-beta not resolved\", \"Upstream activators of the complex not defined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the upstream activation mechanism by showing NIK phosphorylates IKK-alpha at Ser-176 in the activation loop, with phospho-mimetic and dead alleles toggling activity.\",\n      \"evidence\": \"In vitro kinase assay and S176A/S176E site-directed mutagenesis\",\n      \"pmids\": [\"9520446\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish in vivo pathway selectivity of NIK-IKK-alpha\", \"Role of second activation-loop site (S180) not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Quantified the catalytic hierarchy of IKK isoforms, showing IKK-alpha homodimer is weakly active while the heterodimer is most efficient and that additional stress kinases activate IKK-alpha.\",\n      \"evidence\": \"Recombinant homodimer/heterodimer kinetics and overexpression of HPK1/MEKK1\",\n      \"pmids\": [\"10823818\", \"10593898\", \"10523828\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of the heterodimer kinetic advantage untested\", \"Differential basal activity mechanism unexplained\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrated genetically that IKK-alpha and IKK-beta are together indispensable for NF-kappaB activation in vivo, resolving whether the kinases are essential.\",\n      \"evidence\": \"IKK1/IKK2 double-knockout mice and MEFs with kappaB-lacZ reporter\",\n      \"pmids\": [\"10898787\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not separate unique IKK-alpha functions from IKK-beta\", \"Non-canonical pathway not specifically dissected\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Refined the catalytic mechanism by showing IKK-alpha homodimers contain non-equivalent active sites and that activation-loop phosphorylation alters active-site conformation via intramolecular autophosphorylation.\",\n      \"evidence\": \"Recombinant homodimer enzyme kinetics, inhibitor analysis, S176E/S180E mutants\",\n      \"pmids\": [\"12054687\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab in vitro analysis\", \"Physiological consequence of active-site asymmetry untested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified IKK-alpha-specific signaling roles, both as a Vav-1-associated kinase in T-cell costimulation and as the selective mediator of LMP1-induced non-canonical p100 processing, distinguishing it from IKK-beta.\",\n      \"evidence\": \"Co-IP/kinase assays in T cells and IKK-alpha-knockout MEFs with NF-kappaB pathway readouts\",\n      \"pmids\": [\"12626540\", \"14691250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of IKK-alpha selectivity for p100 not structurally defined\", \"Direct p100 phosphorylation by IKK-alpha not shown here\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Revealed kinase-independent and NF-kappaB-independent developmental roles and broadened the substrate landscape to RelA Ser-536, separating IKK-alpha functions from canonical signaling.\",\n      \"evidence\": \"Ikka mutant vs cIkBaDN mouse epistasis in tooth/ectoderm; multi-kinase RelA S536 phosphorylation analysis\",\n      \"pmids\": [\"14960276\", \"15489227\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular targets of NF-kappaB-independent developmental role unknown\", \"RelA S536 phosphorylation has redundant kinase inputs\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established IKK-alpha as a negative checkpoint on canonical IKK-beta activity and assigned distinct cell-type-specific roles in osteoclast and bone biology.\",\n      \"evidence\": \"IKK1-knockout macrophages and hematopoietic/conditional knockouts with functional readouts\",\n      \"pmids\": [\"16116086\", \"15897281\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of IKK-alpha checkpoint on IKK-beta unclear\", \"In vitro vs in vivo discordance in osteoclastogenesis unexplained\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Documented nuclear chromatin-associated functions of IKK-alpha at gene promoters, controlling E2F1 transcription and acetylation, and identified p63 as upstream in epidermal development.\",\n      \"evidence\": \"siRNA, ChIP and co-IP for E2F1; transcriptional assays and mouse genetic complementation for p63\",\n      \"pmids\": [\"16407216\", \"17093266\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct kinase substrate at chromatin not always identified\", \"Generality of promoter recruitment unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined IKK-alpha as a stress- and damage-responsive nuclear chromatin-modifying kinase (ATM-driven nuclear accumulation; H3 Ser-10 phosphorylation) and showed activation-loop sites differentially gate IRF3/7 vs NF-kappaB outputs.\",\n      \"evidence\": \"In vitro kinase assays, ChIP, dominant-negative and S176E/S180E mutant reporter assays, knockout MEFs\",\n      \"pmids\": [\"17700524\", \"18239189\", \"18068231\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab studies for each effector branch\", \"How site-specific phosphorylation routes effector choice mechanistically unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrated epidermal-barrier and innate-defense roles, including RA-regulated transcription in keratinocytes and NF-kappaB-independent ERK-dependent mucin induction.\",\n      \"evidence\": \"Keratinocyte-specific IKK1 knockout with ChIP; dominant-negative/siRNA mucin assays in vivo\",\n      \"pmids\": [\"17351639\", \"17237423\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct IKK-alpha substrates in RA-regulated transcription not defined\", \"Kinase dependence of mucin role not fully resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extended IKK-alpha function to BAFF-R survival signaling, hepatic/bile-duct integrity, and axonal development, revealing redundant and IKK1-specific physiological roles.\",\n      \"evidence\": \"Conditional B-cell and liver knockouts; pharmacological IKK inhibition in neurons\",\n      \"pmids\": [\"18713867\", \"18606991\", \"18321726\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Neuronal study cannot separate IKK-alpha from IKK-beta\", \"Mechanism linking IKK1 to Akt/Erk activation unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified IKK-alpha as a target of bacterial immune evasion and as a SMAD3-associated driver of NF-kappaB-independent EMT, and established its essential developmental role in humans.\",\n      \"evidence\": \"InlC direct binding/infection models; co-IP/ChIP for SMAD3-EMT; human loss-of-function genetics; zebrafish domain-specific rescue\",\n      \"pmids\": [\"20855622\", \"21081648\", \"20961246\", \"20692251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphorylation events in EMT not defined\", \"Human syndrome lacks in vitro mechanistic reconstitution\", \"Kinase vs HLH requirement differs across species\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Solidified IKK-alpha as a nuclear lineage-specifying chromatin kinase by showing direct occupancy and H3 phosphorylation at the Il17a locus during Th17 differentiation, and placed IKK1 upstream of Notch in keratinocytes.\",\n      \"evidence\": \"ChIP and non-activatable IKK-alpha knock-in T cells; NICD rescue of IKK1-null keratinocytes\",\n      \"pmids\": [\"21402739\", \"21435444\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How nuclear IKK-alpha is targeted to specific loci unknown\", \"Direct chromatin substrate repertoire incomplete\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined a kinase-independent structural/regulatory role in chondrocyte hypertrophy and ECM remodeling, and a nuclear lipogenic transcriptional program co-opted by HCV.\",\n      \"evidence\": \"Conditional knockout chondrocytes with kinase-dead rescue; siRNA/inhibitor HCV lipogenesis with SREBP/CBP-p300 readouts\",\n      \"pmids\": [\"24023802\", \"23708292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular partners mediating kinase-independent chondrocyte role not identified\", \"Direct IKK-alpha nuclear substrate in HCV program undefined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked nuclear IKK-alpha stability to a survivin-2B-dependent p73/UVRAG axis controlling the autophagy-apoptosis switch.\",\n      \"evidence\": \"Nuclear co-IP, fractionation, knockdown, in vivo tumor model\",\n      \"pmids\": [\"24556686\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab pathway\", \"Whether IKK-alpha kinase activity is required not established\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mapped the spatial trafficking of IKK-alpha during HCV infection through stress granules to the nucleus, supporting the lipogenesis model.\",\n      \"evidence\": \"Live and fixed imaging, fractionation, co-IP, siRNA of DDX3X/SG components\",\n      \"pmids\": [\"25740981\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trigger for nuclear translocation not defined\", \"Single-lab observation\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided the structural basis for IKK-alpha's selective non-canonical function, showing a hexamer-forming surface required for p100 processing and a RelB competition mechanism setting signaling output.\",\n      \"evidence\": \"Cryo-EM and X-ray structures with hexamer-surface mutagenesis; co-IP mapping of RelB/NIK/IKK1/p100 complex\",\n      \"pmids\": [\"27851956\", \"27678221\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How hexamer assembly is regulated in cells unknown\", \"Structure of the full active signalsome not resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified a specific IKK-alpha substrate (DCNL5 Ser-41) in innate immunity and demonstrated a redundant NF-kappaB-independent pro-survival role of the IKK complex against TNF/RIPK1-driven apoptosis.\",\n      \"evidence\": \"In vitro kinase specificity assays; CRISPR/Cas9n single and double IKK knockouts in human cells\",\n      \"pmids\": [\"29958295\", \"29630899\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of DCNL5 phosphorylation incompletely defined\", \"Mechanism of IKK restraint on RIPK1 unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Confirmed in vivo kinase-independent IKK-alpha function in osteoarthritic cartilage degradation and established IKK-alpha as a lung epithelial tumor suppressor restraining HIF-1alpha.\",\n      \"evidence\": \"Inducible chondrocyte knockout DMM model; inducible AT-II knockout carcinogenesis and NSCLC xenografts with transcriptome profiling\",\n      \"pmids\": [\"31222033\", \"31792060\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which kinase-dead IKK-alpha drives ECM remodeling unknown\", \"Direct link between IKK-alpha and HIF-1alpha regulation undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Dissected cell-type-specific in vivo roles and clarified NIK-IKK coupling, showing IKK-alpha in lymphatic endothelium drives lymph node formation while NIK can activate IKK2 independently of IKK1's enzymatic function.\",\n      \"evidence\": \"Tissue-specific conditional knockouts; NIK interaction-domain knock-in mice with co-IP and pathway assays\",\n      \"pmids\": [\"34810256\", \"41060807\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Distinct effectors in LEC vs hematopoietic compartments unidentified\", \"Structural basis of NIK-IKK2 independent activation unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Suggested post-translational regulation of IKK-alpha by O-GlcNAc-modified NLRX1 to limit IL-1beta in macrophages.\",\n      \"evidence\": \"Co-IP, colocalization, OGT inhibition, IL-1beta measurement\",\n      \"pmids\": [\"35513753\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single co-IP study without reciprocal validation\", \"Direct effect of NLRX1 binding on IKK-alpha kinase activity not shown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How nuclear IKK-alpha is selectively recruited to specific gene loci, and the molecular basis of its kinase-independent structural functions in development and ECM remodeling, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No defined targeting mechanism for nuclear/chromatin IKK-alpha\", \"Kinase-independent effector partners largely unidentified\", \"Full active-signalsome structure not determined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 2, 4, 10, 35]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 2, 4, 16, 27, 35]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [13, 19, 24, 27, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7, 15, 16, 27, 30, 31]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 5, 8, 33]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 11, 23, 27, 39]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [9, 14, 19, 25, 28, 39]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [16, 27, 30]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [23, 30, 38]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [31, 36]}\n    ],\n    \"complexes\": [\"IKK signalsome\"],\n    \"partners\": [\"IKBKB\", \"NEMO\", \"MAP3K14\", \"VAV1\", \"SMAD3\", \"DDX3X\", \"RELB\", \"NFKB2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}